{"content":"<li class=\"n-box-item date-title\" data-end=\"1371700799\" data-start=\"1371614400\" data-txt=\"Friday, December 20, 2019\">Wednesday, June 19, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1095202\" data-ts=\"1371686940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIVE\" target=\"_blank\">FIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1095202\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Below (NASDAQ:FIVE) sinks in the post session after announcing an 8.6M share secondary...</a></h4><p>Five Below (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FIVE\" title=\"Five Below\">FIVE</a>) sinks in the post session after announcing an 8.6M share secondary offering. All of the shares are being offered by selling shareholders, including certain members of Five Below's management team and Board of Directors. The underwriters are expected to have a 30-day option to purchase an additional 1.3M shares to cover over-allotments. <a href=\"https://seekingalpha.com/symbol/FIVE\" title=\"Five Below\">FIVE</a> won't receive any proceeds from the sale. Goldman Sachs, Barclays, Jefferies, Credit Suisse and Deutsche Bank are joint book-running managers. Shares <font color=\"red\">-6%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1095202\" data-linked=\"Five Below (NASDAQ:FIVE) sinks in the post session after announcing an 8.6M share secondary...\" data-tweet=\"$FIVE - Five Below (NASDAQ:FIVE) sinks in the post session after announcing an 8.6M share secondary offering. All of the shares are being offered by selling shareholders, including certain members of Five Below&#39;s management team and Board of Directors. ... https://seekingalpha.com/news/1095202?source=tweet\" data-url=\"https://seekingalpha.com/news/1095202\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1095192\" data-ts=\"1371686333\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECTE\" target=\"_blank\">ECTE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1095192\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Echo Therapeutics (OTC:ECTE +1.9%) says that its priced its full 4.628M share public offering,...</a></h4><p>Echo Therapeutics (<a href=\"https://seekingalpha.com/symbol/ECTE\" title=\"Echo Therapeutics\">OTC:ECTE</a> <font color=\"green\">+1.9%</font>) says that its priced its full 4.628M share public offering, which includes the full over-allotment exercise, at $2.70 per share, an actual 3% premium to today's closing price of $2.62. Demand for the deal was high, and the sale will generate around $12.5M in gross proceeds before the underwriting discount and other offering costs are deducted. Shares <font color=\"green\">+1.9%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1095192\" data-linked=\"Echo Therapeutics (OTC:ECTE +1.9%) says that its priced its full 4.628M share public offering,...\" data-tweet=\"$ECTE - Echo Therapeutics (OTC:ECTE +1.9%) says that its priced its full 4.628M share public offering, which includes the full over-allotment exercise, at $2.70 per share, an actual 3% premium to today&#39;s closing price of $2.62. Demand for the deal was h... https://seekingalpha.com/news/1095192?source=tweet\" data-url=\"https://seekingalpha.com/news/1095192\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1095182\" data-ts=\"1371686325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBIX\" target=\"_blank\">EBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1095182\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ebix&#39;s (NASDAQ:EBIX) merger agreement with a Goldman Sachs affiliate has been terminated. The...</a></h4><p>Ebix's (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EBIX\" title=\"Ebix Inc\">EBIX</a>) merger agreement with a Goldman Sachs affiliate has been terminated. The termination is the result of Ebix's receipt of a letter from a U.S. Attorney for the Northern District of Georgia stating it has \"opened an investigation into allegations of intentional misconduct\" found in recent shareholder class action suits against Ebix. The letter follows <a href=\"https://seekingalpha.com/currents/post/993011\" target=\"_blank\">an SEC investigation</a> into Ebix's accounting launched earlier this year. <a href=\"https://seekingalpha.com/symbol/EBIX\" title=\"Ebix Inc\">EBIX</a> <strong><font color=\"red\">-25%</font></strong> AH. SA contributor <a href=\"https://seekingalpha.com/currents/post/842551\" target=\"_blank\">Gotham City Research</a> has been quite critical of Ebix's accounting for some time.</p><div class=\"tiny-share-widget\" data-id=\"1095182\" data-linked=\"Ebix&#39;s (NASDAQ:EBIX) merger agreement with a Goldman Sachs affiliate has been terminated. The...\" data-tweet=\"$EBIX - Ebix&#39;s (NASDAQ:EBIX) merger agreement with a Goldman Sachs affiliate has been terminated. The termination is the result of Ebix&#39;s receipt of a letter from a U.S. Attorney for the Northern District of Georgia stating it has &quot;opened an investigati... https://seekingalpha.com/news/1095182?source=tweet\" data-url=\"https://seekingalpha.com/news/1095182\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1095102\" data-ts=\"1371678845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZN\" target=\"_blank\">ZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1095102\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zion Oil &amp;amp; Gas (NASDAQ:ZN) says its Board of Directors has approved in-well testing at its...</a></h4><p>Zion Oil &amp; Gas (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ZN\" title=\"Zion Oil &amp; Gas Inc\">ZN</a>) says its Board of Directors <a target=\"_blank\" href=\"http://www.streetinsider.com/Corporate+News/Zion+Oil+%28ZN%29+Plans+In-Well+Testing+of+Elijah+%233/8432773.html\">has approved</a> in-well testing at its Elijah #3 well in the Asher-Menashe License in Israel, in which an application was submitted the country's Petroleum Commissioner for a third one-year extension on April 26. The testing is a key method of obtaining information on the formation fluid and establishing whether a well has found a commercial hydrocarbon reservoir.</p><div class=\"tiny-share-widget\" data-id=\"1095102\" data-linked=\"Zion Oil &amp;amp; Gas (NASDAQ:ZN) says its Board of Directors has approved in-well testing at its...\" data-tweet=\"$ZN - Zion Oil &amp; Gas (NASDAQ:ZN) says its Board of Directors has approved in-well testing at its Elijah #3 well in the Asher-Menashe License in Israel, in which an application was submitted the country&#39;s Petroleum Commissioner for a third one-year exten... https://seekingalpha.com/news/1095102?source=tweet\" data-url=\"https://seekingalpha.com/news/1095102\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1095062\" data-ts=\"1371677940\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHT\" target=\"_blank\">RHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1095062\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Red Hat (NYSE:RHT) guides on its FQ1 call for FQ2 EPS of $0.32-$0.33 and FY13 EPS of...</a></h4><p>Red Hat (NYSE:<a href=\"https://seekingalpha.com/symbol/RHT\" title=\"Red Hat, Inc.\">RHT</a>) guides on its <a href=\"https://seekingalpha.com/currents/post/1094702\" target=\"_blank\">FQ1</a> call for FQ2 EPS of $0.32-$0.33 and FY13 EPS of $1.31-$1.35, in-line with Street estimates of $0.33 and $1.34 and better than feared. Aided by strong demand from telco and cloud customers, FQ1 billings <a href=\"https://twitter.com/Nils1975/status/347463508251799553\" target=\"_blank\">rose 14% Y/Y</a>, a solid improvement from the 9% FQ4 growth that had disappointed some investors. Deferred revenue balance -3% Q/Q and +16% Y/Y to $1.06B, and $179M was spent on buybacks. Shares <font color=\"green\">+3.9%</font> AH, thanks in part to <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1371240000000&amp;chddm=44491&amp;chls=IntervalBasedLine&amp;q=NYSE:RHT&amp;ntsp=0&amp;ei=3yLCUeiPJ9KwiAKW6QE\" target=\"_blank\">low expectations</a>. (PR) (yesterday)</p><div class=\"tiny-share-widget\" data-id=\"1095062\" data-linked=\"Red Hat (NYSE:RHT) guides on its FQ1 call for FQ2 EPS of $0.32-$0.33 and FY13 EPS of...\" data-tweet=\"$RHT - Red Hat (NYSE:RHT) guides on its FQ1 call for FQ2 EPS of $0.32-$0.33 and FY13 EPS of $1.31-$1.35, in-line with Street estimates of $0.33 and $1.34 and better than feared. Aided by strong demand from telco and cloud customers, FQ1 billings rose 14... https://seekingalpha.com/news/1095062?source=tweet\" data-url=\"https://seekingalpha.com/news/1095062\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1095052\" data-ts=\"1371677425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNSR\" target=\"_blank\">FNSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1095052\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After-hours top gainers, as of 5:15 p.m.: FNSR +10%. GME +9%. HW +7%. EDAP +6%. NOK +5%....</a></h4><b>After-hours top gainers, as of 5:15 p.m.:</b> <a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a> <font color=\"green\">+10%</font>. <a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a> <font color=\"green\">+9%</font>. <a href='https://seekingalpha.com/symbol/HW' title='Headwaters Incorporated'>HW</a> <font color=\"green\">+7%</font>. <a href='https://seekingalpha.com/symbol/EDAP' title='EDAP TMS S.A.'>EDAP</a> <font color=\"green\">+6%</font>. <a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a> <font color=\"green\">+5%</font>. <br /><b>After-hours top losers:</b> <a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a> <font color=\"red\">-9%</font>. <a href='https://seekingalpha.com/symbol/ZIXI' title='Zix Corporation'>ZIXI</a> <font color=\"red\">-7%</font>. <a href='https://seekingalpha.com/symbol/SCS' title='Steelcase Inc.'>SCS</a> <font color=\"red\">-4%</font>. <a href='https://seekingalpha.com/symbol/QAI' title='IQ Hedge Multi-Strategy Tracker ETF'>QAI</a> <font color=\"red\">-2%</font>. <a href='https://seekingalpha.com/symbol/GLW' title='Corning Inc.'>GLW</a> <font color=\"red\">-2%</font>.<div class=\"tiny-share-widget\" data-id=\"1095052\" data-linked=\"After-hours top gainers, as of 5:15 p.m.: FNSR +10%. GME +9%. HW +7%. EDAP +6%. NOK +5%....\" data-tweet=\"$FNSR $FNSR $GME - After-hours top gainers, as of 5:15 p.m.: FNSR +10%. GME +9%. HW +7%. EDAP +6%. NOK +5%. After-hours top losers: GASX -9%. ZIXI -7%. SCS -4%. QAI -2%. GLW -2%. https://seekingalpha.com/news/1095052?source=tweet\" data-url=\"https://seekingalpha.com/news/1095052\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094982\" data-ts=\"1371675935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094982\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft (NASDAQ:MSFT) does an about-face, dropping the Xbox One&#39;s Internet verification...</a></h4><p>Microsoft (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MSFT\" title=\"Microsoft Corporation\">MSFT</a>) does an about-face, <a href=\"http://kotaku.com/microsoft-is-removing-xbox-one-drm-514390310\" target=\"_blank\">dropping</a> the Xbox One's Internet verification <a href=\"https://seekingalpha.com/currents/post/1070631\" target=\"_blank\">requirements</a> and all of its used game restrictions. GameStop (NYSE:<a href=\"https://seekingalpha.com/symbol/GME\" title=\"GameStop Corp.\">GME</a>) investors are <em>very</em> pleased, shares <font color=\"green\">+7.8%</font> AH. Microsoft's change-of-heart follows a major backlash from gamers (they were far from appeased by Redmond's <a href=\"http://www.gamespot.com/e3/microsoft-responds-to-xbox-one-backlash-this-isnt-a-sprint-6409849/\" target=\"_blank\">initial response</a>), and plenty of <a href=\"https://seekingalpha.com/currents/post/1078892\" target=\"_blank\">gamer enthusiasm</a> being shown for the PlayStation 4 (NYSE:<a href=\"https://seekingalpha.com/symbol/SNE\" title=\"Sony Corporation\">SNE</a>), both due to its lack of similar restrictions and its lower price.</p><div class=\"tiny-share-widget\" data-id=\"1094982\" data-linked=\"Microsoft (NASDAQ:MSFT) does an about-face, dropping the Xbox One&#39;s Internet verification...\" data-tweet=\"$MSFT $MSFT $GME - Microsoft (NASDAQ:MSFT) does an about-face, dropping the Xbox One&#39;s Internet verification requirements and all of its used game restrictions. GameStop (NYSE:GME) investors are very pleased, shares +7.8% AH. Microsoft&#39;s change-of-heart... https://seekingalpha.com/news/1094982?source=tweet\" data-url=\"https://seekingalpha.com/news/1094982\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094882\" data-ts=\"1371674481\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSYS\" target=\"_blank\">SSYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094882\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stratasys (NASDAQ:SSYS) is acquiring desktop 3D printing upstart MakerBot in an all-stock deal...</a></h4><p>Stratasys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SSYS\" title=\"Stratasys, Inc.\">SSYS</a>) is acquiring desktop 3D printing upstart MakerBot in an all-stock deal that has an initial value of $403M (based on Stratasys' Wednesday close), but which could reach $604M via performance incentives. MakerBot, which has sold 22K+ printers since '09 (11K <a target=\"_blank\" href=\"https://store.makerbot.com/replicator2.html\">Replicator 2</a> units in the last 9 months) and had Q1 revenue of $11.5M, will operate as an independent unit. The deal is expected to be slightly dilutive to 2013 EPS, and accretive by the end of 2014. The companies estimate 35K-40K desktop 3D printers were sold in 2012, and see the market doubling this year. CC at 7AM ET tomorrow (<a target=\"_blank\" href=\"http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.media-server.com%2Fm%2Fp%2F86agynec&amp;esheet=50655539&amp;lan=en-US&amp;anchor=http%3A%2F%2Fwww.media-server.com%2Fm%2Fp%2F86agynec&amp;index=3&amp;md5=e16948f9172f2153b7ee0a2f3f28167a\">webcast</a>). <a href=\"https://seekingalpha.com/symbol/SSYS\" title=\"Stratasys, Inc.\">SSYS</a> <font color=\"green\">+1.7%</font> AH. (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1073302\">previous</a>)</p><div class=\"tiny-share-widget\" data-id=\"1094882\" data-linked=\"Stratasys (NASDAQ:SSYS) is acquiring desktop 3D printing upstart MakerBot in an all-stock deal...\" data-tweet=\"$SSYS - Stratasys (NASDAQ:SSYS) is acquiring desktop 3D printing upstart MakerBot in an all-stock deal that has an initial value of $403M (based on Stratasys&#39; Wednesday close), but which could reach $604M via performance incentives. MakerBot, which has ... https://seekingalpha.com/news/1094882?source=tweet\" data-url=\"https://seekingalpha.com/news/1094882\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094812\" data-ts=\"1371673721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNSR\" target=\"_blank\">FNSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094812\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finisar (NASDAQ:FNSR) +8.9% AH following its FQ4 beat. FQ1 guidance is for revenue of revenue of...</a></h4><p>Finisar (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FNSR\" title=\"Finisar Corporation\">FNSR</a>) <font color=\"green\">+8.9%</font> AH following its <a href=\"https://seekingalpha.com/currents/post/1094652\" target=\"_blank\">FQ4 beat</a>. FQ1 guidance is for revenue of revenue of $245M-$260M and EPS of $0.22-$0.26, mostly above a consensus of $248.9M and $0.20. A 150 bps Q/Q increase in gross margin to 32.2%, caused by a favorable mix, contributed to the EPS beat. Finisar says it's seeing strong demand for 10G/100G Ethernet components for datacom gear - 10G is being <a href=\"http://www.networkworld.com/news/2013/030413-ethernet-switch-market-267360.html\" target=\"_blank\">rapidly adopted</a> in data centers, and some firms are <a href=\"http://www.embedded.com/print/4405142\" target=\"_blank\">starting to embrace</a> 100G. Opex +4% Y/Y. a little above rev. growth of 2%. JDSU <font color=\"green\">+3%</font>, <a href=\"https://seekingalpha.com/symbol/NPTN\" title=\"NeoPhotonics Corporation\">NPTN</a> <font color=\"green\">+4.3%</font>, and <a href=\"https://seekingalpha.com/symbol/CIEN\" title=\"Ciena Corporation\">CIEN</a> <font color=\"green\">+1%</font> in sympathy. <a href=\"https://seekingalpha.com/symbol/FN\" title=\"Fabrinet\">FN</a>, <a href=\"https://seekingalpha.com/symbol/OCLR\" title=\"Oclaro, Inc.\">OCLR</a>, and <a href=\"https://seekingalpha.com/symbol/OPLK\" title=\"Oplink Communications, Inc.\">OPLK</a> could also rally. CC at 5PM ET (<a href=\"http://investor.finisar.com/eventdetail.cfm?eventid=126163\" target=\"_blank\">webcast</a>). (PR)</p><div class=\"tiny-share-widget\" data-id=\"1094812\" data-linked=\"Finisar (NASDAQ:FNSR) +8.9% AH following its FQ4 beat. FQ1 guidance is for revenue of revenue of...\" data-tweet=\"$FNSR $FNSR $VIAV - Finisar (NASDAQ:FNSR) +8.9% AH following its FQ4 beat. FQ1 guidance is for revenue of revenue of $245M-$260M and EPS of $0.22-$0.26, mostly above a consensus of $248.9M and $0.20. A 150 bps Q/Q increase in gross margin to 32.2%, caus... https://seekingalpha.com/news/1094812?source=tweet\" data-url=\"https://seekingalpha.com/news/1094812\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094792\" data-ts=\"1371673472\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SD\" target=\"_blank\">SD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094792\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SandRidge Energy (NYSE:SD) +2.4% AH after naming CFO James Bennett as its new CEO and president,...</a></h4><p>SandRidge Energy (NYSE:<a href=\"https://seekingalpha.com/symbol/SD\" title=\"SandRidge Energy, Inc.\">SD</a>) <font color=\"green\">+2.4%</font> AH after naming CFO James Bennett as its new CEO and president, and appointing lead independent director Jeffrey Serota as interim non-executive chairman. Tom Ward is out, as the board decides new leadership is in the best interests of the company.</p><div class=\"tiny-share-widget\" data-id=\"1094792\" data-linked=\"SandRidge Energy (NYSE:SD) +2.4% AH after naming CFO James Bennett as its new CEO and president,...\" data-tweet=\"$SD - SandRidge Energy (NYSE:SD) +2.4% AH after naming CFO James Bennett as its new CEO and president, and appointing lead independent director Jeffrey Serota as interim non-executive chairman. Tom Ward is out, as the board decides new leadership is in ... https://seekingalpha.com/news/1094792?source=tweet\" data-url=\"https://seekingalpha.com/news/1094792\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094752\" data-ts=\"1371673081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094752\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Not escaping the post-FOMC, post-Bernanke selloff is gold (GLD -1.2%) which falls to $1,349 per...</a></h4><p>Not escaping the post-FOMC, post-Bernanke <a href=\"https://seekingalpha.com/currents/post/1094552\" target=\"_blank\">selloff </a>is gold (GLD <font color=\"red\">-1.2%</font>) which falls to $1,349 per ounce - key support as the technicians like to say as this is the level at which the metal's fast spring slide <a href=\"http://finviz.com/futures_charts.ashx?t=GC&amp;p=d1\" target=\"_blank\">bounced from</a> in both April and May. Underneath that, there's <a href=\"http://finviz.com/futures_charts.ashx?t=GC&amp;p=w1\" target=\"_blank\">nothing but air</a> going all the way back to 2009 and $800 per ounce. Ditto for silver (SLV <font color=\"red\">-1.3%</font>) and maybe even worse as that metal <a href=\"http://finviz.com/futures_charts.ashx?t=SI&amp;p=d1\" target=\"_blank\">has cracked</a> the April and May support.</p><div class=\"tiny-share-widget\" data-id=\"1094752\" data-linked=\"Not escaping the post-FOMC, post-Bernanke selloff is gold (GLD -1.2%) which falls to $1,349 per...\" data-tweet=\"$GLD $SLV $GLD - Not escaping the post-FOMC, post-Bernanke selloff is gold (GLD -1.2%) which falls to $1,349 per ounce - key support as the technicians like to say as this is the level at which the metal&#39;s fast spring slide bounced from in both April an... https://seekingalpha.com/news/1094752?source=tweet\" data-url=\"https://seekingalpha.com/news/1094752\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094742\" data-ts=\"1371673030\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGNX\" target=\"_blank\">PGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094742\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progenics Pharmaceuticals (NASDAQ:PGNX) falls 1.25% AH after announcing a proposed secondary. (PR)</a></h4><p>Progenics Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PGNX\" title=\"Progenics Pharmaceuticals Inc.\">PGNX</a>) falls <font color=\"red\">1.25%</font> AH after announcing a proposed secondary. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1094742\" data-linked=\"Progenics Pharmaceuticals (NASDAQ:PGNX) falls 1.25% AH after announcing a proposed secondary. (PR)\" data-tweet=\"$PGNX - Progenics Pharmaceuticals (NASDAQ:PGNX) falls 1.25% AH after announcing a proposed secondary. (PR) https://seekingalpha.com/news/1094742?source=tweet\" data-url=\"https://seekingalpha.com/news/1094742\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094732\" data-ts=\"1371672874\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094732\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nokia (NYSE:NOK) +2.6% AH after the WSJ reports Microsoft (NASDAQ:MSFT) held advanced talks to...</a></h4><p>Nokia (NYSE:<a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a>) <font color=\"green\">+2.6%</font> AH after the <em>WSJ</em> reports Microsoft (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MSFT\" title=\"Microsoft Corporation\">MSFT</a>) <a target=\"_blank\" href=\"http://online.wsj.com/article/SB10001424127887323393804578555783340654630.html\">held advanced talks</a> to buy Nokia's phone business, and was \"close to an oral agreement\" at one point, but adds discussions broke down in part due to price and concerns about Nokia's competitive positioning. One source says the talks \"took place as recently as this month, but aren't likely to be revived.\"</p><div class=\"tiny-share-widget\" data-id=\"1094732\" data-linked=\"Nokia (NYSE:NOK) +2.6% AH after the WSJ reports Microsoft (NASDAQ:MSFT) held advanced talks to...\" data-tweet=\"$NOK $NOK $MSFT - Nokia (NYSE:NOK) +2.6% AH after the WSJ reports Microsoft (NASDAQ:MSFT) held advanced talks to buy Nokia&#39;s phone business, and was &quot;close to an oral agreement&quot; at one point, but adds discussions broke down in part due to price and conc... https://seekingalpha.com/news/1094732?source=tweet\" data-url=\"https://seekingalpha.com/news/1094732\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094702\" data-ts=\"1371672432\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RHT\" target=\"_blank\">RHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094702\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Red Hat (NYSE:RHT): Q1 EPS of $0.32 beats by $0.01. Revenue of $363M (+15% Y/Y) beats by $3.16M....</a></h4><b>Red Hat (NYSE:<a href=\"https://seekingalpha.com/symbol/RHT\" title=\"Red Hat, Inc.\">RHT</a>):</b> Q1 EPS of $0.32 <font color=\"green\">beats by $0.01</font>. Revenue of $363M (+15% Y/Y) <font color=\"green\">beats by $3.16M</font>. Shares  <font color=\"green\">+3.1%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1094702\" data-linked=\"Red Hat (NYSE:RHT): Q1 EPS of $0.32 beats by $0.01. Revenue of $363M (+15% Y/Y) beats by $3.16M....\" data-tweet=\"$RHT - Red Hat (NYSE:RHT): Q1 EPS of $0.32 beats by $0.01. Revenue of $363M (+15% Y/Y) beats by $3.16M. Shares +3.1% AH. (PR) https://seekingalpha.com/news/1094702?source=tweet\" data-url=\"https://seekingalpha.com/news/1094702\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094692\" data-ts=\"1371672354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094692\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron (NASDAQ:MU): Q1 EPS of $0.04 beats by $0.01. Revenue of $2.3B beats by $0.06B. Shares -1%...</a></h4><b>Micron (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a>):</b> Q1 EPS of $0.04 <font color=\"green\">beats by $0.01</font>. Revenue of $2.3B <font color=\"green\">beats by $0.06B</font>. Shares  <font color=\"red\">-1%</font> AH. (PR)<div class=\"tiny-share-widget\" data-id=\"1094692\" data-linked=\"Micron (NASDAQ:MU): Q1 EPS of $0.04 beats by $0.01. Revenue of $2.3B beats by $0.06B. Shares -1%...\" data-tweet=\"$MU - Micron (NASDAQ:MU): Q1 EPS of $0.04 beats by $0.01. Revenue of $2.3B beats by $0.06B. Shares -1% AH. (PR) https://seekingalpha.com/news/1094692?source=tweet\" data-url=\"https://seekingalpha.com/news/1094692\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094682\" data-ts=\"1371672311\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CYTK\" target=\"_blank\">CYTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094682\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cytokinetics (CYTK -3.7%) gives back some of yesterday&#39;s gains made after the company announced...</a></h4><p>Cytokinetics (<a href=\"https://seekingalpha.com/symbol/CYTK\" title=\"Cytokinetics, Incorporated\">CYTK</a> <font color=\"red\">-3.7%</font>) gives back some of yesterday's gains made after the company <a href=\"https://seekingalpha.com/market_currents/post/1091742\" target=\"_blank\">announced that results</a> from its Phase IIb clinical trial, ATOMIC-AHF, have been accepted for presentation during a Hot Line Late Breaking Trials Session at the European Society of Cardiology Congress 2013.</p><div class=\"tiny-share-widget\" data-id=\"1094682\" data-linked=\"Cytokinetics (CYTK -3.7%) gives back some of yesterday&#39;s gains made after the company announced...\" data-tweet=\"$CYTK - Cytokinetics (CYTK -3.7%) gives back some of yesterday&#39;s gains made after the company announced that results from its Phase IIb clinical trial, ATOMIC-AHF, have been accepted for presentation during a Hot Line Late Breaking Trials Session at the... https://seekingalpha.com/news/1094682?source=tweet\" data-url=\"https://seekingalpha.com/news/1094682\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094612\" data-ts=\"1371671085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRD\" target=\"_blank\">TLRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094612\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">George Zimmer on his ouster from Men&#39;s Wearhouse (MW -0.8%): &quot;Over the past several months I...</a></h4><p>George Zimmer <a href=\"http://www.nbcnews.com/business/mens-wearhouse-icon-wont-way-he-looks-hes-out-6C10378086\" target=\"_blank\">on his ouster</a> from Men's Wearhouse (MW <font color=\"red\">-0.8%</font>): \"Over the past several months I have expressed my concerns to the board about the direction the company is currently heading. Instead of fostering the kind of dialogue in the boardroom that has in part contributed to our success, the board has inappropriately chosen to silence my concerns through termination as an executive officer.\" In addition to saying Zimmer might have \"<a href=\"http://www.streetinsider.com/Management+Changes/Mens+Wearhouse+%28MW%29+Founder+George+Zimmer+Axed%2C+Reports+Say+he+Had+Trouble+Letting+Go/8431381.html\" target=\"_blank\">had trouble letting go,</a>\" Stifel notes that MW still \"has the legal right to his image.\"</p><div class=\"tiny-share-widget\" data-id=\"1094612\" data-linked=\"George Zimmer on his ouster from Men&#39;s Wearhouse (MW -0.8%): &quot;Over the past several months I...\" data-tweet=\"$TLRD - George Zimmer on his ouster from Men&#39;s Wearhouse (MW -0.8%): &quot;Over the past several months I have expressed my concerns to the board about the direction the company is currently heading. Instead of fostering the kind of dialogue in the boardroom... https://seekingalpha.com/news/1094612?source=tweet\" data-url=\"https://seekingalpha.com/news/1094612\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094592\" data-ts=\"1371670422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RYCEY\" target=\"_blank\">RYCEY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094592\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Paris Air Show: Rolls-Royce (OTCPK:RYCEY -1.4%) says it wants to cut costs right across its...</a></h4><a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=Paris%20Air%20Show\">Paris Air Show:</a> Rolls-Royce (<a href=\"https://seekingalpha.com/symbol/RYCEY\" title=\"Rolls Royce Holdings plc ADR\">OTCPK:RYCEY</a> <font color=\"red\">-1.4%</font>) says it <a href=\"http://www.nasdaq.com/article/air-show-rolls-royce-shakes-up-aero-engineering-business-to-cut-costs-20130618-00577\" target=\"_blank\">wants to cut costs</a> right across its aero-engine business to match the productivity of its major competitors, even as the U.K. engineering company ramps up production to meet booming demand for more fuel-efficient passenger jets. The company says it plans to slim down its portfolio, targeting increased sales of a narrower range of products.<div class=\"tiny-share-widget\" data-id=\"1094592\" data-linked=\"Paris Air Show: Rolls-Royce (OTCPK:RYCEY -1.4%) says it wants to cut costs right across its...\" data-tweet=\"$RYCEY - Paris Air Show: Rolls-Royce (OTCPK:RYCEY -1.4%) says it wants to cut costs right across its aero-engine business to match the productivity of its major competitors, even as the U.K. engineering company ramps up production to meet booming demand... https://seekingalpha.com/news/1094592?source=tweet\" data-url=\"https://seekingalpha.com/news/1094592\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094552\" data-ts=\"1371669184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGNC\" target=\"_blank\">AGNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094552\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Markets start to fall in earnest as the reality of a tapering and then ending in QE sinks in -...</a></h4><p>Markets start to fall in earnest as the reality of a tapering and<a href=\"https://seekingalpha.com/currents/post/1094502\" target=\"_blank\"> then ending in QE</a> sinks in - even as the chairman is at pains to prove it's anything but a tightening move. The DJIA (<a href=\"https://seekingalpha.com/symbol/DIA\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a> <font color=\"red\">-0.8%</font>) is off 145 points as the 10-year Treasury yield soars 15 bps to 2.33%, its highest level in 2 years. Reversing sizable early gains is the mREIT sector (<a href=\"https://seekingalpha.com/symbol/REM\" title=\"iShares Mortgage Real Estate Capped ETF\">REM</a> <font color=\"red\">-2.3%</font>) - a leveraged holder of the paper the Fed will no longer be buying - with American Capital (<a href=\"https://seekingalpha.com/symbol/AGNC\" title=\"AGNC Investment Corp.\">AGNC</a> <font color=\"red\">-2%</font>), (<a href=\"https://seekingalpha.com/symbol/MTGE\" title=\"MTGE Investment Corp.\">MTGE</a> <font color=\"red\">-1.5%</font>), Annaly (<a href=\"https://seekingalpha.com/symbol/NLY\" title=\"Annaly Capital Management, Inc.\">NLY</a> <font color=\"red\">-2.2%</font>), Invesco (<a href=\"https://seekingalpha.com/symbol/IVR\" title=\"Invesco Mortgage Capital Inc.\">IVR</a> <font color=\"red\">-2.5%</font>), Two Harbors (<a href=\"https://seekingalpha.com/symbol/TWO\" title=\"Two Harbors Investment Corp.\">TWO</a> <font color=\"red\">-3.5%</font>), and Anworth (<a href=\"https://seekingalpha.com/symbol/ANH\" title=\"Anworth Mortgage Asset Corporation\">ANH</a> <font color=\"red\">-2.2%</font>) leading the way. The greenback (<a href=\"https://seekingalpha.com/symbol/UUP\" title=\"Invesco DB USD Bullish ETF\">UUP</a> <font color=\"green\">+0.9%</font>) continues to fly higher.</p><div class=\"tiny-share-widget\" data-id=\"1094552\" data-linked=\"Markets start to fall in earnest as the reality of a tapering and then ending in QE sinks in -...\" data-tweet=\"$AGNC $DIA $REM - Markets start to fall in earnest as the reality of a tapering and then ending in QE sinks in - even as the chairman is at pains to prove it&#39;s anything but a tightening move. The DJIA (DIA -0.8%) is off 145 points as the 10-year Treasur... https://seekingalpha.com/news/1094552?source=tweet\" data-url=\"https://seekingalpha.com/news/1094552\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094562\" data-ts=\"1371669137\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094562\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onglyza, a diabetes drug co-marketed by Bristol-Myers Squibb (BMY -1.3%) and AstraZeneca (AZN...</a></h4><p>Onglyza, a diabetes drug co-marketed by Bristol-Myers Squibb (<a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a> <font color=\"red\">-1.3%</font>) and AstraZeneca (<a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a> <font color=\"red\">-1.2%</font>), <a href=\"http://www.streetinsider.com/Corporate+News/Bristol-Myers+%28BMY%29%2C+AstraZeneca+%28AZN%29+SAVOR-TIMI-53+Misses+Primary+Efficacy+Endpoint+in+Phase+4/8429774.html\" target=\"_blank\">failed to reduce</a> the risk of heart attacks and related disease compared with a placebo in a big clinical trial. The drug was approved by the  FDA in 2009 to treat type 2 diabetes, but required a large clinical trial to assess its cardiovascular safety. The outcome disappointed those hoping for a boost to the market for type 2 diabetes pills, and could have implications for other companies with similar drugs, including Merck's (NYSE:<a href=\"https://seekingalpha.com/symbol/MRK\" title=\"Merck &amp; Co Inc.\">MRK</a>) blockbuster Januvia.</p><div class=\"tiny-share-widget\" data-id=\"1094562\" data-linked=\"Onglyza, a diabetes drug co-marketed by Bristol-Myers Squibb (BMY -1.3%) and AstraZeneca (AZN...\" data-tweet=\"$BMY $BMY $AZN - Onglyza, a diabetes drug co-marketed by Bristol-Myers Squibb (BMY -1.3%) and AstraZeneca (AZN -1.2%), failed to reduce the risk of heart attacks and related disease compared with a placebo in a big clinical trial. The drug was approved ... https://seekingalpha.com/news/1094562?source=tweet\" data-url=\"https://seekingalpha.com/news/1094562\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094532\" data-ts=\"1371668371\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094532\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lazard comes to the defense of Buy-rated Vanda Pharmaceuticals (VNDA -22%) after TheStreet&#39;s...</a></h4><p>Lazard comes to the defense of Buy-rated Vanda Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/VNDA\" title=\"Vanda Pharmaceuticals Inc.\">VNDA</a> <font color=\"red\">-22%</font>) after <i>TheStreet's</i> Adam Feuerstein tanks the stock with questions about the design of a Phase 3 trial for Tasimelteon (<a href=\"https://seekingalpha.com/currents/post/1093192\" target=\"_blank\">previous</a>). Feuerstein's assessment is \"<a href=\"http://www.streetinsider.com/Analyst+Comments/Lazard+Capital+Defends+Vanda+%28VNDA%29%2C+Calls+Reports+%27Inflammatory%27/8431807.html\" target=\"_blank\">surprisingly inflammatory,</a>\" analyst Joshua Schimmer says, noting that the sell-off could be a buying opportunity given management's confidence in the drug.</p><div class=\"tiny-share-widget\" data-id=\"1094532\" data-linked=\"Lazard comes to the defense of Buy-rated Vanda Pharmaceuticals (VNDA -22%) after TheStreet&#39;s...\" data-tweet=\"$VNDA - Lazard comes to the defense of Buy-rated Vanda Pharmaceuticals (VNDA -22%) after TheStreet&#39;s Adam Feuerstein tanks the stock with questions about the design of a Phase 3 trial for Tasimelteon (previous). Feuerstein&#39;s assessment is &quot;surprisingly ... https://seekingalpha.com/news/1094532?source=tweet\" data-url=\"https://seekingalpha.com/news/1094532\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094482\" data-ts=\"1371667584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSHWQ\" target=\"_blank\">OSHWQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094482\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orchard Supply (OSH -59%) says the U.S. Bankruptcy Court has approved all of the First Day...</a></h4><p>Orchard Supply (OSH <font color=\"red\">-59%</font>) says the U.S. Bankruptcy Court has approved all of the First Day Motions related to its voluntary Chapter 11. The motions collectively will enable the company to continue operating its business as usual as it completes its Chapter 11 case.</p><div class=\"tiny-share-widget\" data-id=\"1094482\" data-linked=\"Orchard Supply (OSH -59%) says the U.S. Bankruptcy Court has approved all of the First Day...\" data-tweet=\"$OSHWQ - Orchard Supply (OSH -59%) says the U.S. Bankruptcy Court has approved all of the First Day Motions related to its voluntary Chapter 11. The motions collectively will enable the company to continue operating its business as usual as it completes... https://seekingalpha.com/news/1094482?source=tweet\" data-url=\"https://seekingalpha.com/news/1094482\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094472\" data-ts=\"1371667341\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094472\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aside from Linn Energy (LINE +6%) (earlier), SandRidge Energy (SD +3.2%) also enjoys a sustained...</a></h4><p>Aside from Linn Energy (LINE <font color=\"green\">+6%</font>) (<a href=\"https://seekingalpha.com/currents/post/1094032\" target=\"_blank\">earlier</a>), SandRidge Energy (<a href=\"https://seekingalpha.com/symbol/SD\" title=\"SandRidge Energy, Inc.\">SD</a> <font color=\"green\">+3.2%</font>) also enjoys a sustained rise from Lee Cooperman's CNBC comments. He thinks SD's assets are worth close to $10/share and expects management changes in the coming weeks. The <a href=\"https://twitter.com/FastMoneyLydia/status/347412142208712707\" target=\"_blank\">full list</a> of stocks Cooperman likes (<a href=\"http://www.cnbc.com/id/100828773\" target=\"_blank\">video</a>): <a href=\"https://seekingalpha.com/symbol/TCRD\" title=\"THL Credit\">TCRD</a>, <a href=\"https://seekingalpha.com/symbol/ESRX\" title=\"Express Scripts, Inc.\">ESRX</a>, <a href=\"https://seekingalpha.com/symbol/HAL\" title=\"Halliburton Company\">HAL</a>, <a href=\"https://seekingalpha.com/symbol/RIG\" title=\"Transocean Ltd.\">RIG</a>, <a href=\"https://seekingalpha.com/symbol/QCOM\" title=\"Qualcomm Inc.\">QCOM</a>, <a href=\"https://seekingalpha.com/symbol/MSI\" title=\"Motorola Solutions, Inc.\">MSI</a>, <a href=\"https://seekingalpha.com/symbol/CIM\" title=\"Chimera Investment Corporation\">CIM</a>, <a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a>, <a href=\"https://seekingalpha.com/symbol/DISH\" title=\"DISH Network Corporation\">DISH</a>, <a href=\"https://seekingalpha.com/symbol/ARP\" title=\"Atlas Resource Partners, L.P.\">ARP</a>.</p><div class=\"tiny-share-widget\" data-id=\"1094472\" data-linked=\"Aside from Linn Energy (LINE +6%) (earlier), SandRidge Energy (SD +3.2%) also enjoys a sustained...\" data-tweet=\"$ROAN $ROAN $SD - Aside from Linn Energy (LINE +6%) (earlier), SandRidge Energy (SD +3.2%) also enjoys a sustained rise from Lee Cooperman&#39;s CNBC comments. He thinks SD&#39;s assets are worth close to $10/share and expects management changes in the coming w... https://seekingalpha.com/news/1094472?source=tweet\" data-url=\"https://seekingalpha.com/news/1094472\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094442\" data-ts=\"1371666820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGEN\" target=\"_blank\">AGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094442\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Agenus (AGEN +4.2%) rise for the second straight day bringing gains since around 1:30...</a></h4><p>Shares of Agenus (<a href=\"https://seekingalpha.com/symbol/AGEN\" title=\"Agenus\">AGEN</a> <font color=\"green\">+4.2%</font>) rise for the second straight day bringing gains since around 1:30 Tuesday to nearly <font color=\"green\">7%</font>. Maxim <a href=\"http://www.benzinga.com/news/13/06/3686225/maxim-group-initiates-coverage-on-agenus-inc-at-buy-announces-19-00-pt\" target=\"_blank\">initiated the shares at Buy</a> with a lofty $19 price target yesterday.</p><div class=\"tiny-share-widget\" data-id=\"1094442\" data-linked=\"Shares of Agenus (AGEN +4.2%) rise for the second straight day bringing gains since around 1:30...\" data-tweet=\"$AGEN - Shares of Agenus (AGEN +4.2%) rise for the second straight day bringing gains since around 1:30 Tuesday to nearly 7%. Maxim initiated the shares at Buy with a lofty $19 price target yesterday. https://seekingalpha.com/news/1094442?source=tweet\" data-url=\"https://seekingalpha.com/news/1094442\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094392\" data-ts=\"1371665967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094392\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Sonic (SONC +1.8%) skate higher on the back of a Morgan Stanley upgrade to Equalweight...</a></h4>Shares of Sonic (<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a> <font color='green'>+1.8%</font>) skate higher on the back of a <a href=\"http://www.streetinsider.com/Upgrades/Morgan+Stanley+Upgrades+Sonic+%28SONC%29+to+Equalweight/8429800.html\" target=\"_blank\">Morgan Stanley upgrade</a> to Equalweight from Underweight.<div class=\"tiny-share-widget\" data-id=\"1094392\" data-linked=\"Shares of Sonic (SONC +1.8%) skate higher on the back of a Morgan Stanley upgrade to Equalweight...\" data-tweet=\"$SONC - Shares of Sonic (SONC +1.8%) skate higher on the back of a Morgan Stanley upgrade to Equalweight from Underweight. https://seekingalpha.com/news/1094392?source=tweet\" data-url=\"https://seekingalpha.com/news/1094392\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094382\" data-ts=\"1371665863\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPTP\" target=\"_blank\">RPTP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094382\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raptor Pharmaceutical (RPTP +1.1%) says its Procysbi delayed-release capsules for the treatment...</a></h4><p>Raptor Pharmaceutical (<a href=\"https://seekingalpha.com/symbol/RPTP\" title=\"Raptor Pharmaceutical Corp.\">RPTP</a> <font color=\"green\">+1.1%</font>) says its Procysbi delayed-release capsules for the treatment of nephropathic cystinosis are now available in the U.S. for shipment. Nephropathic cystinosis is a rare, life-threatening metabolic lysosomal storage disorder that causes toxic accumulation of cystine in all cells, tissues, and organs in the body.</p><div class=\"tiny-share-widget\" data-id=\"1094382\" data-linked=\"Raptor Pharmaceutical (RPTP +1.1%) says its Procysbi delayed-release capsules for the treatment...\" data-tweet=\"$RPTP - Raptor Pharmaceutical (RPTP +1.1%) says its Procysbi delayed-release capsules for the treatment of nephropathic cystinosis are now available in the U.S. for shipment. Nephropathic cystinosis is a rare, life-threatening metabolic lysosomal storag... https://seekingalpha.com/news/1094382?source=tweet\" data-url=\"https://seekingalpha.com/news/1094382\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094372\" data-ts=\"1371665627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094372\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bond prices (TLT -0.7%) slip following the more upbeat assessment of the economy from the FOMC....</a></h4><p>Bond prices (<a href=\"https://seekingalpha.com/symbol/tlt\" title=\"iShares Barclays 20+ Year Treasury Bond ETF\">TLT</a> <font color=\"red\">-0.7%</font>) slip following the <a href=\"https://seekingalpha.com/currents/post/1094332\" target=\"_blank\">more upbeat</a> assessment of the economy from the FOMC. Higher growth and lower unemployment <a href=\"https://seekingalpha.com/currents/post/1094362\" target=\"_blank\">projections</a> spell maybe a quicker schedule for tapering and eventual tightening, but materially lower inflation expectations say the opposite. Stocks give up a bit of ground as well, the S&amp;P 500 (<a href=\"https://seekingalpha.com/symbol/spy\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a> <font color=\"red\">-0.3%</font>). The dollar (<a href=\"https://seekingalpha.com/symbol/uup\" title=\"PowerShares DB USD Bull ETF\">UUP</a> <font color=\"green\">+0.3%</font>) pops higher across the board.</p><div class=\"tiny-share-widget\" data-id=\"1094372\" data-linked=\"Bond prices (TLT -0.7%) slip following the more upbeat assessment of the economy from the FOMC....\" data-tweet=\"$TLT $SPY $UUP - Bond prices (TLT -0.7%) slip following the more upbeat assessment of the economy from the FOMC. Higher growth and lower unemployment projections spell maybe a quicker schedule for tapering and eventual tightening, but materially lower i... https://seekingalpha.com/news/1094372?source=tweet\" data-url=\"https://seekingalpha.com/news/1094372\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094342\" data-ts=\"1371665004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWS\" target=\"_blank\">NWS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094342\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts weren&#39;t surprised by the when-issued trading in Australia of the new companies emerging...</a></h4><p>Analysts <a href=\"http://www.hollywoodreporter.com/news/new-news-corp-stock-drops-571690\" target=\"_blank\">weren't surprised</a> by the <a href=\"https://seekingalpha.com/currents/post/1092692\" target=\"_blank\">when-issued trading</a> in Australia of the new companies emerging from the split of News Corp. (<a href=\"https://seekingalpha.com/symbol/NWS\" title=\"News Corporation\">NWS</a>, <a href=\"https://seekingalpha.com/symbol/NWSA\" title=\"News Corporation\">NWSA</a>). In their debut in Sydney, 21st Century Fox (Fox movie, pay TV and free TV busines, Sky Deutschland, Sky Italia, part of BskyB ) rose over 5% while the new News Corp. (Wall Street Journal, The Sun, Barron's, Australian media assets) dropped 3%.</p><div class=\"tiny-share-widget\" data-id=\"1094342\" data-linked=\"Analysts weren&#39;t surprised by the when-issued trading in Australia of the new companies emerging...\" data-tweet=\"$NWS $NWS $NWSA - Analysts weren&#39;t surprised by the when-issued trading in Australia of the new companies emerging from the split of News Corp. (NWS, NWSA). In their debut in Sydney, 21st Century Fox (Fox movie, pay TV and free TV busines, Sky Deutschla... https://seekingalpha.com/news/1094342?source=tweet\" data-url=\"https://seekingalpha.com/news/1094342\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094312\" data-ts=\"1371664761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMLP\" target=\"_blank\">CMLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094312\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inergy (NRGY -37.5%) completes its distribution to unitholders of the ~56.4M common units it...</a></h4><p>Inergy (NRGY <font color=\"red\">-37.5%</font>) completes its distribution to unitholders of the ~56.4M  common units it previously held in Inergy Midstream (NRGM <font color=\"red\">-1.3%</font>), marking the first step in Crestwood Midstream's (<a href=\"https://seekingalpha.com/symbol/CMLP\" title=\"Crestwood Midstream Partners LP\">CMLP</a> <font color=\"green\">+1%</font>) <a href=\"https://seekingalpha.com/currents/post/999851\" target=\"_blank\">takeover</a> of NRGY, which is expected to close by Q3. Raymond James calls the move a \"<a target=\"_blank\" href=\"http://finance.yahoo.com/news/inergy-distributes-inergy-midstream-units-155852420.html\">structural cleanup</a>\" ahead of CMLP's takeover.</p><div class=\"tiny-share-widget\" data-id=\"1094312\" data-linked=\"Inergy (NRGY -37.5%) completes its distribution to unitholders of the ~56.4M common units it...\" data-tweet=\"$CMLP - Inergy (NRGY -37.5%) completes its distribution to unitholders of the ~56.4M common units it previously held in Inergy Midstream (NRGM -1.3%), marking the first step in Crestwood Midstream&#39;s (CMLP +1%) takeover of NRGY, which is expected to clos... https://seekingalpha.com/news/1094312?source=tweet\" data-url=\"https://seekingalpha.com/news/1094312\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094302\" data-ts=\"1371664388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBIX\" target=\"_blank\">NBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094302\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neurocrine Biosciences (NBIX +2.7%) moves up today after being initiated by Oppenheimer with an...</a></h4>Neurocrine Biosciences (<a href='https://seekingalpha.com/symbol/NBIX' title='Neurocrine Biosciences, Inc.'>NBIX</a> <font color=\"green\">+2.7%</font>) moves up today after <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/06/3686929/update-oppenheimer-initiates-coverage-on-neurocrine-bios\" target=\"_blank\">being initiated</a> by Oppenheimer with an Outperform rating. The firm says that its sees blockbuster potential for elagolix, with Phase 3 endometriosis results expected in H114 and Phase 2 results in H214. A secondary asset, NBI-98854, a Vesicular Mono-Amine Transporter 2 compound for treating tardive dyskinesia, is risky, but only modest value is baked in.<div class=\"tiny-share-widget\" data-id=\"1094302\" data-linked=\"Neurocrine Biosciences (NBIX +2.7%) moves up today after being initiated by Oppenheimer with an...\" data-tweet=\"$NBIX - Neurocrine Biosciences (NBIX +2.7%) moves up today after being initiated by Oppenheimer with an Outperform rating. The firm says that its sees blockbuster potential for elagolix, with Phase 3 endometriosis results expected in H114 and Phase 2 re... https://seekingalpha.com/news/1094302?source=tweet\" data-url=\"https://seekingalpha.com/news/1094302\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094282\" data-ts=\"1371663318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKTR\" target=\"_blank\">NKTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094282\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nektar Therapeutics (NKTR +8.8%) rises after saying NKTR-181 (basically an opioid which doesn&#39;t...</a></h4><p>Nektar Therapeutics (<a href=\"https://seekingalpha.com/symbol/NKTR\" title=\"Nektar Therapeutics\">NKTR</a> <font color=\"green\">+8.8%</font>) rises after saying NKTR-181 (basically an opioid which doesn't act like an opioid in terms of euphoric effects) \"rated similar to placebo in 'drug liking' and 'feeling high' scores\" compared to oxycodone. The drug's slow rate of entry into the brain is intended to reduce the euphoria that is often cited as a contributor to opioid analgesic addiction. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1094282\" data-linked=\"Nektar Therapeutics (NKTR +8.8%) rises after saying NKTR-181 (basically an opioid which doesn&#39;t...\" data-tweet=\"$NKTR - Nektar Therapeutics (NKTR +8.8%) rises after saying NKTR-181 (basically an opioid which doesn&#39;t act like an opioid in terms of euphoric effects) &quot;rated similar to placebo in &#39;drug liking&#39; and &#39;feeling high&#39; scores&quot; compared to oxycodone. The dru... https://seekingalpha.com/news/1094282?source=tweet\" data-url=\"https://seekingalpha.com/news/1094282\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094262\" data-ts=\"1371663186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TENX\" target=\"_blank\">TENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094262\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Oxygen Biotherapeutics (OXBT +10.9%) extend yesterday&#39;s 2.6% closing gain after the...</a></h4><p>Shares of Oxygen Biotherapeutics (OXBT <font color=\"green\">+10.9%</font>) extend yesterday's 2.6% closing gain after the company announced on yesterday that it's completed FDA requested studies on its Oxycyte, a treatment for traumatic brain injury and other brain conditions. The company says the results were positive overall, but it will continue to conduct more studies on the treatment.</p><div class=\"tiny-share-widget\" data-id=\"1094262\" data-linked=\"Shares of Oxygen Biotherapeutics (OXBT +10.9%) extend yesterday&#39;s 2.6% closing gain after the...\" data-tweet=\"$TENX - Shares of Oxygen Biotherapeutics (OXBT +10.9%) extend yesterday&#39;s 2.6% closing gain after the company announced on yesterday that it&#39;s completed FDA requested studies on its Oxycyte, a treatment for traumatic brain injury and other brain conditi... https://seekingalpha.com/news/1094262?source=tweet\" data-url=\"https://seekingalpha.com/news/1094262\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094252\" data-ts=\"1371662767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNA\" target=\"_blank\">ARNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094252\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">An AMA designation might have no legal standing but new legislation aimed at Medicare coverage...</a></h4><p>An AMA designation might have <a href=\"https://seekingalpha.com/currents/post/1092712\" target=\"_blank\">no legal standing</a> but <a href=\"http://www.benzinga.com/news/13/06/3690006/senators-carper-murkowski-representatives-cassidy-kind-introduce-bill-to-help-red\" target=\"_blank\">new legislation</a> aimed at Medicare coverage for weight-loss drugs could change that. Sens. Tom Carper and Lisa Murkowski and Reps. Bill Cassidy, M.D. and Ron Kind have introduced <i>The Treat and Reduce Obesity Act </i>which would, among other things , \"allow Medicare to cover additional obesity treatments (beyond surgery) such as prescription drugs for chronic weight management.\" Leerink's Marko Kozul says the news \"could <a href=\"http://www.streetinsider.com/Analyst+Comments/Bill+for+Medicare+Coverage%2C+AMA+Designation+Positive+for+Obesity+Drug+Makers+%28ARNA%29+%28VVUS%29+%28OREX%29+-+Leerink+Swann/8431547.html\" target=\"_blank\">provide further upside</a> to current estimates\" for Arena (<a href=\"https://seekingalpha.com/symbol/ARNA\" title=\"Arena Pharmaceuticals, Inc.\">ARNA</a> <font color=\"green\">+2.7%</font>), Orexigen (<a href=\"https://seekingalpha.com/symbol/OREX\" title=\"Orexigen Therapeutics, Inc.\">OREX</a> <font color=\"green\">+0.5%</font>), and Vivus (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+7.7%</font>).</p><div class=\"tiny-share-widget\" data-id=\"1094252\" data-linked=\"An AMA designation might have no legal standing but new legislation aimed at Medicare coverage...\" data-tweet=\"$ARNA $ARNA $OREX - An AMA designation might have no legal standing but new legislation aimed at Medicare coverage for weight-loss drugs could change that. Sens. Tom Carper and Lisa Murkowski and Reps. Bill Cassidy, M.D. and Ron Kind have introduced The... https://seekingalpha.com/news/1094252?source=tweet\" data-url=\"https://seekingalpha.com/news/1094252\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094242\" data-ts=\"1371662208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094242\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of clinical stage biopharmaceutical company Intercept Pharmaceuticals (NASDAQ:ICPT) are...</a></h4><p>Shares of clinical stage biopharmaceutical company Intercept Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ICPT\" title=\"Intercept Pharmaceuticals\">ICPT</a>) are now up over <font color=\"green\">13%</font> after pricing its <a href=\"https://seekingalpha.com/market_currents/post/1092982\" target=\"_blank\">public offering</a> of 1.73M shares at $33.01 per share in line with yesterday's close.</p><div class=\"tiny-share-widget\" data-id=\"1094242\" data-linked=\"Shares of clinical stage biopharmaceutical company Intercept Pharmaceuticals (NASDAQ:ICPT) are...\" data-tweet=\"$ICPT - Shares of clinical stage biopharmaceutical company Intercept Pharmaceuticals (NASDAQ:ICPT) are now up over 13% after pricing its public offering of 1.73M shares at $33.01 per share in line with yesterday&#39;s close. https://seekingalpha.com/news/1094242?source=tweet\" data-url=\"https://seekingalpha.com/news/1094242\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094212\" data-ts=\"1371661637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNOV\" target=\"_blank\">MNOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094212\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MediciNova (MNOV +29.6%) soars after the company says its glial attenuator MN-166 may reduce...</a></h4><p>MediciNova (<a href=\"https://seekingalpha.com/symbol/MNOV\" title=\"MediciNova, Inc.\">MNOV</a> <font color=\"green\">+29.6%</font>) soars after the company says its glial attenuator MN-166 may reduce methamphetamine's neurotoxic inflammation and might also \"attenuate other actions contributing to methamphetamine dependence.\" The company plans to initiate a Phase 2 trial \"later this summer.\" (PR)</p><div class=\"tiny-share-widget\" data-id=\"1094212\" data-linked=\"MediciNova (MNOV +29.6%) soars after the company says its glial attenuator MN-166 may reduce...\" data-tweet=\"$MNOV - MediciNova (MNOV +29.6%) soars after the company says its glial attenuator MN-166 may reduce methamphetamine&#39;s neurotoxic inflammation and might also &quot;attenuate other actions contributing to methamphetamine dependence.&quot; The company plans to init... https://seekingalpha.com/news/1094212?source=tweet\" data-url=\"https://seekingalpha.com/news/1094212\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094202\" data-ts=\"1371661601\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRD\" target=\"_blank\">TLRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094202\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The mystery behind the ouster of Men&#39;s Wearhouse (MW -1.9%) founder George Zimmer lies behind...</a></h4>The mystery behind the ouster of Men's Wearhouse (MW <font color='red'>-1.9%</font>) founder George Zimmer lies behind the doors at the company where the exec had significant difficulty giving up control, according to Stifel Nicolaus. The investment firm <a href=\"http://abcnews.go.com/Business/effectiveness-mens-wearhouse-george-zimmer-spokesperson-review-analyst/story?id=19436560#.UcHjgPk4T0s\" target=\"_blank\">backs</a> its Buy rating on the retailer, noting current management including creator director Joseph Abboud are on the right track.<div class=\"tiny-share-widget\" data-id=\"1094202\" data-linked=\"The mystery behind the ouster of Men&#39;s Wearhouse (MW -1.9%) founder George Zimmer lies behind...\" data-tweet=\"$TLRD - The mystery behind the ouster of Men&#39;s Wearhouse (MW -1.9%) founder George Zimmer lies behind the doors at the company where the exec had significant difficulty giving up control, according to Stifel Nicolaus. The investment firm backs its Buy r... https://seekingalpha.com/news/1094202?source=tweet\" data-url=\"https://seekingalpha.com/news/1094202\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094112\" data-ts=\"1371660328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNOV\" target=\"_blank\">MNOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094112\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: MNOV +28%. AVHI +18%. DGLY +18%. ARL +16%. TRUE +13%. AQQ +13%. DQ +13%....</a></h4><b>Midday top 10 gainers:</b> <a href='https://seekingalpha.com/symbol/MNOV' title='MediciNova, Inc.'>MNOV</a> <font color=\"green\">+28%</font>. <a href='https://seekingalpha.com/symbol/AVHI' title='AV Homes, Inc'>AVHI</a> <font color=\"green\">+18%</font>. <a href='https://seekingalpha.com/symbol/DGLY' title='Digital Ally, Inc.'>DGLY</a> <font color=\"green\">+18%</font>. <a href='https://seekingalpha.com/symbol/ARL' title='American Realty Investors, Inc.'>ARL</a> <font color=\"green\">+16%</font>. <a href='https://seekingalpha.com/symbol/TRUE' title='TrueCar, Inc'>TRUE</a> <font color=\"green\">+13%</font>. <a href='https://seekingalpha.com/symbol/AQQ' title='American Spectrum Realty, Inc'>AQQ</a> <font color=\"green\">+13%</font>. <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color=\"green\">+13%</font>. <a href='https://seekingalpha.com/symbol/ASYS' title='Amtech Systems, Inc.'>ASYS</a> <font color=\"green\">+12%</font>. MFRI <font color=\"green\">+12%</font>. <a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color=\"green\">+11%</font>. <br /><b>Midday top 10 Losers:</b> OSH <font color=\"red\">-63%</font>. NRGY <font color=\"red\">-38%</font>. <a href='https://seekingalpha.com/symbol/VNDA' title='Vanda Pharmaceuticals Inc.'>VNDA</a> <font color=\"red\">-24%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color=\"red\">-20%</font>. FMAR <font color=\"red\">-16%</font>. <a href='https://seekingalpha.com/symbol/TTEK' title='Tetra Tech, Inc.'>TTEK</a> <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/VTSS' title='Vitesse Semiconductor Corp.'>VTSS</a> <font color=\"red\">-12%</font>. <a href='https://seekingalpha.com/symbol/CPGI' title='China Shengda Packaging Group, Inc.'>CPGI</a> <font color=\"red\">-11%</font>. <a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a> <font color=\"red\">-10%</font>. BIOD <font color=\"red\">-10%</font>.<div class=\"tiny-share-widget\" data-id=\"1094112\" data-linked=\"Midday top 10 gainers: MNOV +28%. AVHI +18%. DGLY +18%. ARL +16%. TRUE +13%. AQQ +13%. DQ +13%....\" data-tweet=\"$MNOV $MNOV $AVHI - Midday top 10 gainers: MNOV +28%. AVHI +18%. DGLY +18%. ARL +16%. TRUE +13%. AQQ +13%. DQ +13%. ASYS +12%. MFRI +12%. ICPT +11%. Midday top 10 Losers: OSH -63%. NRGY -38%. VNDA -24%. ZN -20%. FMAR -16%. TTEK -13%. VTSS -12%. CPGI -11... https://seekingalpha.com/news/1094112?source=tweet\" data-url=\"https://seekingalpha.com/news/1094112\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1094022\" data-ts=\"1371659185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PPIH\" target=\"_blank\">PPIH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1094022\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MFRI (MFRI +12%) pops as the company announces $55M in new orders, including additions to two...</a></h4><p>MFRI (MFRI <font color=\"green\">+12%</font>) pops as the company announces $55M in new orders, including additions to two landmark projects in Saudi Arabia and piping to support the construction of flow lines in the Gulf of Mexico. The company noted however, that $25M of the orders were already reported in its Q1 backlog.</p><div class=\"tiny-share-widget\" data-id=\"1094022\" data-linked=\"MFRI (MFRI +12%) pops as the company announces $55M in new orders, including additions to two...\" data-tweet=\"$PPIH - MFRI (MFRI +12%) pops as the company announces $55M in new orders, including additions to two landmark projects in Saudi Arabia and piping to support the construction of flow lines in the Gulf of Mexico. The company noted however, that $25M of t... https://seekingalpha.com/news/1094022?source=tweet\" data-url=\"https://seekingalpha.com/news/1094022\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093842\" data-ts=\"1371656150\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GENE\" target=\"_blank\">GENE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093842\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Genetic Technologies (GENE -1.1%) says its subsidiary Phenogen Sciences has executed an...</a></h4><p>Genetic Technologies (<a href=\"https://seekingalpha.com/symbol/GENE\" title=\"GENETIC TECHNOLOGIES LTD\">GENE</a> <font color=\"red\">-1.1%</font>) says its subsidiary Phenogen Sciences has <a href=\"http://www.streetinsider.com/Press+Releases/Genetic+Technologies+Executes+Agreement+With+Further+Nationwide+Provider+Network+for+BREVAGen%28TM%29/8429591.html\" target=\"_blank\">executed an agreement</a> with FedMed to use its national provider network. FedMed's network includes more than 550K, 60K ancillary care providers and 4K hospitals nationwide, with more than 40M covered individuals.</p><div class=\"tiny-share-widget\" data-id=\"1093842\" data-linked=\"Genetic Technologies (GENE -1.1%) says its subsidiary Phenogen Sciences has executed an...\" data-tweet=\"$GENE - Genetic Technologies (GENE -1.1%) says its subsidiary Phenogen Sciences has executed an agreement with FedMed to use its national provider network. FedMed&#39;s network includes more than 550K, 60K ancillary care providers and 4K hospitals nationwid... https://seekingalpha.com/news/1093842?source=tweet\" data-url=\"https://seekingalpha.com/news/1093842\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093802\" data-ts=\"1371655409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLUE\" target=\"_blank\">BLUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093802\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">bluebird bio (NASDAQ:BLUE) opens for trade at about $25, nearly 50% higher than the IPO price of...</a></h4><p>bluebird bio (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BLUE\" title=\"bluebird bio, Inc.\">BLUE</a>) opens for trade at about $25, <font color=\"green\">nearly 50% higher</font> than the IPO price of $17. The <a href=\"https://seekingalpha.com/currents/post/1093332\" target=\"_blank\">IPO itself</a> priced above the expected $14-$16 range and was upsized from 5M to 5.9M shares.</p><div class=\"tiny-share-widget\" data-id=\"1093802\" data-linked=\"bluebird bio (NASDAQ:BLUE) opens for trade at about $25, nearly 50% higher than the IPO price of...\" data-tweet=\"$BLUE - bluebird bio (NASDAQ:BLUE) opens for trade at about $25, nearly 50% higher than the IPO price of $17. The IPO itself priced above the expected $14-$16 range and was upsized from 5M to 5.9M shares. https://seekingalpha.com/news/1093802?source=tweet\" data-url=\"https://seekingalpha.com/news/1093802\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093782\" data-ts=\"1371655203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093782\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Street reacts favorably to Nvidia&#39;s (NVDA +7.3%) decision to license its GPU cores and...</a></h4><p>The Street reacts favorably to Nvidia's (<a href=\"https://seekingalpha.com/symbol/NVDA\" title=\"NVIDIA Corporation\">NVDA</a> <font color=\"green\">+7.3%</font>) decision to <a href=\"https://seekingalpha.com/currents/post/1092382\" target=\"_blank\">license its GPU cores</a> and related IP to other mobile processor developers, rather than simply pin its mobile hopes on Tegra sales. \"If there was ever a way for Nvidia to get into Apple, the IP licensing angle is likely it,\" <a href=\"http://blogs.barrons.com/techtraderdaily/2013/06/19/nvda-licensing-route-to-aapl-says-raymond-james-not-says-evercore/?mod=BOLBlog&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+barrons%2Ftechtraderdaily%2Ffeed+%28BARRONS.com+Blog%3A+Tech+Trader+Daily%29\" target=\"_blank\">says Raymond James</a>, which thinks the move could also limit traction for ARM's (<a href=\"https://seekingalpha.com/symbol/ARMH\" title=\"ARM Holdings, plc\">ARMH</a> <font color=\"red\">-0.8%</font>) Mali GPU cores. Evercore is less optimistic about Apple, stating checks point to \"significant <a href=\"http://www.macrumors.com/2013/05/29/apple-hires-at-least-a-dozen-former-amd-employees-for-an-orlando-gpu-team-still-hiring-more/\" target=\"_blank\">internal GPU design efforts</a>\" at the company. It views Samsung as a possibility, but adds the Korean electronics giant is \"cycling through IP vendors and chip suppliers.\"</p><div class=\"tiny-share-widget\" data-id=\"1093782\" data-linked=\"The Street reacts favorably to Nvidia&#39;s (NVDA +7.3%) decision to license its GPU cores and...\" data-tweet=\"$NVDA $NVDA $ARMH - The Street reacts favorably to Nvidia&#39;s (NVDA +7.3%) decision to license its GPU cores and related IP to other mobile processor developers, rather than simply pin its mobile hopes on Tegra sales. &quot;If there was ever a way for Nvidia t... https://seekingalpha.com/news/1093782?source=tweet\" data-url=\"https://seekingalpha.com/news/1093782\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093762\" data-ts=\"1371654541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SOL\" target=\"_blank\">SOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093762\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReneSola (SOL +4.9%) spikes higher after SA contributor Sneha Shah argues a low cost structure...</a></h4><p>ReneSola (<a href=\"https://seekingalpha.com/symbol/SOL\" title=\"ReneSola Ltd.\">SOL</a> <font color=\"green\">+4.9%</font>) spikes higher after SA contributor <a href=\"https://seekingalpha.com/article/1510232-renesola-multi-bagger-idea-to-profit-from-solar-trade-wars-and-a-return-to-supply-demand-normalcy\" target=\"_blank\">Sneha Shah</a> argues a low cost structure and <a href=\"https://seekingalpha.com/currents/post/902041\" target=\"_blank\">diminishing competition</a> in the solar wafer and polysilicon markets will allow the company to keep gaining share (it recently passed <a href=\"https://seekingalpha.com/symbol/LDK\" title=\"LDK Solar Co., Ltd.\">LDK</a> to be the world's #2 wafer vendor), and that shares are due to rally after underperforming Chinese peers with stronger Japanese exposure. Shah also sees gross margin bottoming - it's expected to rise to 3%-5% in Q2 after coming in at -2% in Q1 - and predicts ReneSola will become a top-10 module supplier in 2013, with a 4%-5% share. 12% of the float was shorted as of May 31.</p><div class=\"tiny-share-widget\" data-id=\"1093762\" data-linked=\"ReneSola (SOL +4.9%) spikes higher after SA contributor Sneha Shah argues a low cost structure...\" data-tweet=\"$SOL $SOL $LDK - ReneSola (SOL +4.9%) spikes higher after SA contributor Sneha Shah argues a low cost structure and diminishing competition in the solar wafer and polysilicon markets will allow the company to keep gaining share (it recently passed LDK t... https://seekingalpha.com/news/1093762?source=tweet\" data-url=\"https://seekingalpha.com/news/1093762\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093682\" data-ts=\"1371652464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WSCI\" target=\"_blank\">WSCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093682\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSI Industries (WSCI -7%) slides after reporting FQ3 net income of $106K, or $0.04 per diluted...</a></h4><p>WSI Industries (<a href=\"https://seekingalpha.com/symbol/WSCI\" title=\"WSI Industries Inc.\">WSCI</a> <font color=\"red\">-7%</font>) slides after reporting FQ3 net income of $106K, or $0.04 per diluted share, down from $598K, or $0.21 per diluted share, in the prior year third quarter. Sales were also lower, totaling $9.2M, down 3% from $9.5M Y/Y. The company cites declines in its energy business, and startup costs in new programs in its recreational vehicle market as well its new firearms business for the miss. The company also declared a quarterly dividend of $.04 per share.</p><div class=\"tiny-share-widget\" data-id=\"1093682\" data-linked=\"WSI Industries (WSCI -7%) slides after reporting FQ3 net income of $106K, or $0.04 per diluted...\" data-tweet=\"$WSCI - WSI Industries (WSCI -7%) slides after reporting FQ3 net income of $106K, or $0.04 per diluted share, down from $598K, or $0.21 per diluted share, in the prior year third quarter. Sales were also lower, totaling $9.2M, down 3% from $9.5M Y/Y. Th... https://seekingalpha.com/news/1093682?source=tweet\" data-url=\"https://seekingalpha.com/news/1093682\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093642\" data-ts=\"1371651813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093642\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofA/Merrill upgrades Adobe (ADBE +6.1%) to Buy in the wake of its FQ2 EPS beat and strong...</a></h4><a href=\"http://www.streetinsider.com/Upgrades/UPDATE%3A+BofAMerrill+Lynch+Upgrades+Adobe+%28ADBE%29+to+Buy/8429815.html\" target=\"_blank\">BofA/Merrill</a> upgrades Adobe (<a href=\"https://seekingalpha.com/symbol/ADBE\" title=\"Adobe Systems Incorporated\">ADBE</a> <font color=\"green\">+6.1%</font>) to Buy in the wake of its <a href=\"https://seekingalpha.com/currents/post/1092112\" target=\"_blank\">FQ2 EPS beat</a> and <a href=\"https://seekingalpha.com/currents/post/1092202\" target=\"_blank\">strong Creative Cloud adds</a>: the firm is upbeat about CC into 2015, and sees Adobe converting much of its Creative Suite base. <a href=\"http://www.streetinsider.com/Analyst+Comments/Adobe+%28ADBE%29+Posts+Positive+Creative+Cloud+Subscriber+Surprise+in+Q2+-+Jefferies/8429836.html\" target=\"_blank\">Jefferies</a> notes CC net adds of 221K beat a consensus of ~185K. Mentioned on the <a href=\"https://seekingalpha.com/article/1509222-adobe-systems-management-discusses-q2-2013-results-earnings-call-transcript\" target=\"_blank\">earnings call</a>: the majority of paid CC subs are individual members; Adobe is evaluating new options for CC pricing (<a href=\"https://seekingalpha.com/currents/post/1091802\" target=\"_blank\">previous</a>); \"targeted promotions\" could hurt CC ARPU in the near-term; and Adobe thinks its infrastructure and analytics tools will allow <a href=\"http://www.adobe.com/solutions/digital-marketing.html\" target=\"_blank\">Marketing Cloud</a> to remain differentiated in the face of <a href=\"https://seekingalpha.com/currents/post/1062211\" target=\"_blank\">new competition</a>. Ad software rival Marketo (<a href=\"https://seekingalpha.com/symbol/MKTO\" title=\"Marketo\">MKTO</a> <font color=\"green\">+10.1%</font>) is in sympathy.<div class=\"tiny-share-widget\" data-id=\"1093642\" data-linked=\"BofA/Merrill upgrades Adobe (ADBE +6.1%) to Buy in the wake of its FQ2 EPS beat and strong...\" data-tweet=\"$ADBE $ADBE $MKTO - BofA/Merrill upgrades Adobe (ADBE +6.1%) to Buy in the wake of its FQ2 EPS beat and strong Creative Cloud adds: the firm is upbeat about CC into 2015, and sees Adobe converting much of its Creative Suite base. Jefferies notes CC net ... https://seekingalpha.com/news/1093642?source=tweet\" data-url=\"https://seekingalpha.com/news/1093642\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093612\" data-ts=\"1371651415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEVO\" target=\"_blank\">GEVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093612\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gevo (GEVO +6.2%) continues to rise on momentum from yesterday&#39;s news that it has resumed...</a></h4><p>Gevo (<a href=\"https://seekingalpha.com/symbol/GEVO\" title=\"Gevo, Inc.\">GEVO</a> <font color=\"green\">+6.2%</font>) continues to rise on momentum from <a href=\"https://seekingalpha.com/currents/post/1091762\" target=\"_blank\">yesterday's news</a> that it has resumed production of isobutanol at its Minnesota plant. But Raymond James <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Raymond+James+Downgrades+Gevo%2C+Inc.+%28GEVO%29+to+Market+Perform/8429869.html\" target=\"_blank\">downgrades</a> shares to Market Perform, seeing production challenges ahead and positive margins unlikely to emerge before Q1 2014, with the next plant perhaps not coming online until beyond  2014.</p><div class=\"tiny-share-widget\" data-id=\"1093612\" data-linked=\"Gevo (GEVO +6.2%) continues to rise on momentum from yesterday&#39;s news that it has resumed...\" data-tweet=\"$GEVO - Gevo (GEVO +6.2%) continues to rise on momentum from yesterday&#39;s news that it has resumed production of isobutanol at its Minnesota plant. But Raymond James downgrades shares to Market Perform, seeing production challenges ahead and positive mar... https://seekingalpha.com/news/1093612?source=tweet\" data-url=\"https://seekingalpha.com/news/1093612\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093592\" data-ts=\"1371650762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CENX\" target=\"_blank\">CENX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093592\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Century Aluminum (CENX -2.5%) is downgraded to Underperform from Neutral with a $9 price target...</a></h4><p>Century Aluminum (<a href=\"https://seekingalpha.com/symbol/CENX\" title=\"Century Aluminum Company\">CENX</a> <font color=\"red\">-2.5%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/06/3688749/update-bank-of-america-downgrades-century-aluminum-on-re\" target=\"_blank\">downgraded</a> to Underperform from Neutral with a $9 price target at BAML, which says its newly lowered estimated 2013 LME price of $0.87/lb. vs. $0.93 offsets an eventual benefit from CENX's recently negotiated lower power costs. The firm also notes sentiment toward added  aluminum capacity globally has soured.</p><div class=\"tiny-share-widget\" data-id=\"1093592\" data-linked=\"Century Aluminum (CENX -2.5%) is downgraded to Underperform from Neutral with a $9 price target...\" data-tweet=\"$CENX - Century Aluminum (CENX -2.5%) is downgraded to Underperform from Neutral with a $9 price target at BAML, which says its newly lowered estimated 2013 LME price of $0.87/lb. vs. $0.93 offsets an eventual benefit from CENX&#39;s recently negotiated low... https://seekingalpha.com/news/1093592?source=tweet\" data-url=\"https://seekingalpha.com/news/1093592\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093572\" data-ts=\"1371650600\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093572\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Goodyear Tire (GT +2.9%) trade higher as industry factors such as the price of rubber...</a></h4><p>Shares of Goodyear Tire (<a href=\"https://seekingalpha.com/symbol/GT\" title=\"Goodyear Tire &amp; Rubber Co.\">GT</a> <font color=\"green\">+2.9%</font>) trade higher as industry factors such as the price of rubber and overall automobile demand stay in the company's favor. Goodyear is also in the midst of some <a href=\"http://www.fayobserver.com/articles/2013/06/18/1264273?sac=fo.local\" target=\"_blank\">labor negotiations</a> with a steel workers union which could impact future costs.</p><div class=\"tiny-share-widget\" data-id=\"1093572\" data-linked=\"Shares of Goodyear Tire (GT +2.9%) trade higher as industry factors such as the price of rubber...\" data-tweet=\"$GT - Shares of Goodyear Tire (GT +2.9%) trade higher as industry factors such as the price of rubber and overall automobile demand stay in the company&#39;s favor. Goodyear is also in the midst of some labor negotiations with a steel workers union which co... https://seekingalpha.com/news/1093572?source=tweet\" data-url=\"https://seekingalpha.com/news/1093572\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093552\" data-ts=\"1371650181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093552\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macquarie&#39;s Kevin Smithen downgrades Sprint (S -3.5%) to Neutral after Dish decides to pass on...</a></h4><p>Macquarie's Kevin Smithen <a href=\"http://www.streetinsider.com/Downgrades/UPDATE%3A+Macquarie+Downgrades+Sprint+%28S%29+to+Neutral/8429884.html\" target=\"_blank\">downgrades</a> Sprint (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"red\">-3.5%</font>) to Neutral after <a href=\"https://seekingalpha.com/currents/post/1092542\" target=\"_blank\">Dish decides to pass</a> on making a new bid for the #3 U.S. mobile carrier before a Tuesday deadline. In addition to the lack of a counterbid, Smithen is worried about <a href=\"https://seekingalpha.com/currents/post/1089592\" target=\"_blank\">the unresolved battle</a> over Clearwire, and the fact Sprint is about to enter a period of heavy spending and negative free cash flow.</p><div class=\"tiny-share-widget\" data-id=\"1093552\" data-linked=\"Macquarie&#39;s Kevin Smithen downgrades Sprint (S -3.5%) to Neutral after Dish decides to pass on...\" data-tweet=\"$S - Macquarie&#39;s Kevin Smithen downgrades Sprint (S -3.5%) to Neutral after Dish decides to pass on making a new bid for the #3 U.S. mobile carrier before a Tuesday deadline. In addition to the lack of a counterbid, Smithen is worried about the unresolv... https://seekingalpha.com/news/1093552?source=tweet\" data-url=\"https://seekingalpha.com/news/1093552\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093542\" data-ts=\"1371650076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRD\" target=\"_blank\">TLRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093542\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Men&#39;s Wearhouse (MW -0.7%) narrows its premarket loss quite a bit as the news of the firing of...</a></h4><p>Men's Wearhouse (MW <font color=\"red\">-0.7%</font>) narrows its <a href=\"https://seekingalpha.com/currents/post/1093392\" target=\"_blank\">premarket loss</a> quite a bit as the news of the firing of its founder is digested. Though a termination - instead of a resignation - signals there's more to the story, some forward-looking investors are jumping in on the prospect that a change of direction will benefit the retailer.</p><div class=\"tiny-share-widget\" data-id=\"1093542\" data-linked=\"Men&#39;s Wearhouse (MW -0.7%) narrows its premarket loss quite a bit as the news of the firing of...\" data-tweet=\"$TLRD - Men&#39;s Wearhouse (MW -0.7%) narrows its premarket loss quite a bit as the news of the firing of its founder is digested. Though a termination - instead of a resignation - signals there&#39;s more to the story, some forward-looking investors are jumpi... https://seekingalpha.com/news/1093542?source=tweet\" data-url=\"https://seekingalpha.com/news/1093542\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093522\" data-ts=\"1371649583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNXL\" target=\"_blank\">UNXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093522\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniPixel (UNXL +5.3%) jumps out of the gate after announcing it has finished building out a...</a></h4><p>UniPixel (<a href=\"https://seekingalpha.com/symbol/UNXL\" title=\"Uni-Pixel, Inc.\">UNXL</a> <font color=\"green\">+5.3%</font>) jumps out of the gate after announcing it has finished building out a 7.5K-square foot Texas office and wet lab facility that will support its UniBoss touch sensor manufacturing ramp. The company adds its employee count is up to 32, and that a motion for summary judgment in its breach of contract dispute with CIT is currently pending. Shares have been mostly <a target=\"_blank\" href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1371240000000&amp;chddm=4397&amp;chls=IntervalBasedLine&amp;q=NASDAQ:UNXL&amp;ntsp=0&amp;ei=crTBUci4D7HEiwK_2QE\">treading water</a> in June after crashing in May.</p><div class=\"tiny-share-widget\" data-id=\"1093522\" data-linked=\"UniPixel (UNXL +5.3%) jumps out of the gate after announcing it has finished building out a...\" data-tweet=\"$UNXL - UniPixel (UNXL +5.3%) jumps out of the gate after announcing it has finished building out a 7.5K-square foot Texas office and wet lab facility that will support its UniBoss touch sensor manufacturing ramp. The company adds its employee count is ... https://seekingalpha.com/news/1093522?source=tweet\" data-url=\"https://seekingalpha.com/news/1093522\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093462\" data-ts=\"1371648955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLD\" target=\"_blank\">CLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093462\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jefferies&#39; Biren Amin hikes the price target on Celldex Therapeutics (CLD +0.7%) to $19 from $15...</a></h4><p>Jefferies' Biren Amin <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/06/3689029/update-jefferies-raises-pt-on-celldex-therapeutics-on-ke\" target=\"_blank\">hikes the price target</a> on Celldex Therapeutics (<a href=\"https://seekingalpha.com/symbol/CLD\" title=\"Cloud Peak Energy, Inc.\">CLD</a> <font color=\"green\">+0.7%</font>) to $19 from $15 citing potential royalties from rindopepimut and CDX-011.</p><div class=\"tiny-share-widget\" data-id=\"1093462\" data-linked=\"Jefferies&#39; Biren Amin hikes the price target on Celldex Therapeutics (CLD +0.7%) to $19 from $15...\" data-tweet=\"$CLD $CLDPQ - Jefferies&#39; Biren Amin hikes the price target on Celldex Therapeutics (CLD +0.7%) to $19 from $15 citing potential royalties from rindopepimut and CDX-011. https://seekingalpha.com/news/1093462?source=tweet\" data-url=\"https://seekingalpha.com/news/1093462\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093422\" data-ts=\"1371648398\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UBNT\" target=\"_blank\">UBNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093422\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ubiquiti (NASDAQ:UBNT) +2.5% after JMP starts coverage with an Outperform and $21 PT....</a></h4>Ubiquiti (NASDAQ:<a href='https://seekingalpha.com/symbol/UBNT' title='Ubiquiti Networks, Inc.'>UBNT</a>) <font color=\"green\">+2.5%</font> after <a href=\"http://www.streetinsider.com/New+Coverage/JMP+Securities+Starts+Ubiquiti+Networks+%28UBNT%29+at+Market+Outperform/8429862.html\" target=\"_blank\">JMP starts coverage</a> with an Outperform and $21 PT. <a href=\"https://seekingalpha.com/currents/post/1088492\" target=\"_blank\">BofA/Merrill</a> started coverage with a Buy two days ago. Though short interest has been <a href=\"http://www.nasdaq.com/symbol/ubnt/short-interest\" target=\"_blank\">gradually declining</a> over the last 10 months, 17% of the float was still shorted as of May 31.<div class=\"tiny-share-widget\" data-id=\"1093422\" data-linked=\"Ubiquiti (NASDAQ:UBNT) +2.5% after JMP starts coverage with an Outperform and $21 PT....\" data-tweet=\"$UBNT $UI - Ubiquiti (NASDAQ:UBNT) +2.5% after JMP starts coverage with an Outperform and $21 PT. BofA/Merrill started coverage with a Buy two days ago. Though short interest has been gradually declining over the last 10 months, 17% of the float was sti... https://seekingalpha.com/news/1093422?source=tweet\" data-url=\"https://seekingalpha.com/news/1093422\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093412\" data-ts=\"1371648295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KERX\" target=\"_blank\">KERX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093412\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on J.P. Morgan&#39;s Keryx BioPharma (NASDAQ:KERX) initiation: Zerenex (I, II) has...</a></h4><p>More on J.P. Morgan's Keryx BioPharma (NASDAQ:<a href=\"https://seekingalpha.com/symbol/KERX\" title=\"Keryx Biopharmaceuticals, Inc.\">KERX</a>) <a href=\"https://seekingalpha.com/currents/post/1093082\" target=\"_blank\">initiation</a>: Zerenex (<a href=\"https://seekingalpha.com/currents/post/1059761\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/933691\" target=\"_blank\">II</a>) has \"pharmacoeconomic advantages [that] <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/06/3688820/update-j-p-morgan-initiates-keryx-biopharmaceuticals-at-\" target=\"_blank\">could drive rapid uptake</a> in the price sensitive end stage renal disease market,\" analyst Cory Kasimov says. Additionally a \"deep dive\" analysis has JPM \"increasingly comfortable\" with the issues that have weighed on the shares recently.</p><div class=\"tiny-share-widget\" data-id=\"1093412\" data-linked=\"More on J.P. Morgan&#39;s Keryx BioPharma (NASDAQ:KERX) initiation: Zerenex (I, II) has...\" data-tweet=\"$KERX - More on J.P. Morgan&#39;s Keryx BioPharma (NASDAQ:KERX) initiation: Zerenex (I, II) has &quot;pharmacoeconomic advantages [that] could drive rapid uptake in the price sensitive end stage renal disease market,&quot; analyst Cory Kasimov says. Additionally a &quot;d... https://seekingalpha.com/news/1093412?source=tweet\" data-url=\"https://seekingalpha.com/news/1093412\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093392\" data-ts=\"1371647994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JOSB\" target=\"_blank\">JOSB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093392\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Jos. A Bank Clothiers (NASDAQ:JOSB) could see some action with rival Men&#39;s Wearhouse...</a></h4><p>Shares of Jos. A Bank Clothiers (NASDAQ:<a href=\"https://seekingalpha.com/symbol/JOSB\" title=\"Jos. A. Bank Clothiers, Inc.\">JOSB</a>) could see some action with rival Men's Wearhouse (MW) taking the dramatic step of <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1093352\">firing</a> its founder. SA contributor Money Investor already made the <a target=\"_blank\" href=\"https://seekingalpha.com/article/1507402-jos-a-bank-buy-one-share-and-get-two-free?source=kizur\">case</a> that Jos. A Bank looks undervalued compared to Men's Wearhouse and could attract a buyer due to its strong fundamentals. Premarket: MW <font color=\"red\">-7.1%</font> premarket, JOSB inactive.</p><div class=\"tiny-share-widget\" data-id=\"1093392\" data-linked=\"Shares of Jos. A Bank Clothiers (NASDAQ:JOSB) could see some action with rival Men&#39;s Wearhouse...\" data-tweet=\"$JOSB $JOSB $TLRD - Shares of Jos. A Bank Clothiers (NASDAQ:JOSB) could see some action with rival Men&#39;s Wearhouse (MW) taking the dramatic step of firing its founder. SA contributor Money Investor already made the case that Jos. A Bank looks undervalue... https://seekingalpha.com/news/1093392?source=tweet\" data-url=\"https://seekingalpha.com/news/1093392\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093372\" data-ts=\"1371647717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093372\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Market preview: U.S. stock futures remain flat as investors look to be staying well out of the...</a></h4><b>Market preview: </b> U.S. stock futures remain flat as investors look to be staying well out of the way until Ben Bernanke has his say later today. For those interested in something other than the \"will they or won't they\" tapering saga, Sprint is <font color=\"red\">-3.4%</font> as its acquisition process heads towards a <a href=\"https://seekingalpha.com/currents/post/1092542\" target=\"_blank\">Japanese endgame</a>, while Adobe <font color=\"green\">jumps 7.3%</font> following earnings and Alcatel-Lucent <font color=\"green\">climbs 4.8%</font> on news of its <a href=\"https://seekingalpha.com/currents/post/1092612\" target=\"_blank\">revamp</a>. Ongoing: <a href=\"https://seekingalpha.com/currents/search?query=Paris%20Air%20Show\" target=\"_blank\">Paris Air Show</a><div class=\"tiny-share-widget\" data-id=\"1093372\" data-linked=\"Market preview: U.S. stock futures remain flat as investors look to be staying well out of the...\" data-tweet=\"Market preview: U.S. stock futures remain flat as investors look to be staying well out of the way until Ben Bernanke has his say later today. For those interested in something other than the &quot;will they or won&#39;t they&quot; tapering saga, Sprint is -3.4% as i... https://seekingalpha.com/news/1093372?source=tweet\" data-url=\"https://seekingalpha.com/news/1093372\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093352\" data-ts=\"1371647475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRD\" target=\"_blank\">TLRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093352\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Men&#39;s Wearhouse (MW) fires George Zimmer from his position as executive chairman and says it...</a></h4><p>Men's Wearhouse (MW) fires George Zimmer from his position as executive chairman and says it will postpone its annual meeting as it seeks new director candidates. For those curious, Zimmer is the guy from the Men's Wearhouse commercials with the personal guarantee. MW <font color=\"red\">-6.6%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1093352\" data-linked=\"Men&#39;s Wearhouse (MW) fires George Zimmer from his position as executive chairman and says it...\" data-tweet=\"$TLRD - Men&#39;s Wearhouse (MW) fires George Zimmer from his position as executive chairman and says it will postpone its annual meeting as it seeks new director candidates. For those curious, Zimmer is the guy from the Men&#39;s Wearhouse commercials with the... https://seekingalpha.com/news/1093352?source=tweet\" data-url=\"https://seekingalpha.com/news/1093352\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093312\" data-ts=\"1371647146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093312\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: ADBE +7%. UNXL +7%. CYTK +7%. SRPT +7%.Losers: OSH -46%. VNDA -16%.</a></h4><b>Premarket gainers:</b> <a href=\"https://seekingalpha.com/symbol/ADBE\" title=\"Adobe Systems Incorporated\">ADBE</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/UNXL\" title=\"Uni-Pixel, Inc.\">UNXL</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/CYTK\" title=\"Cytokinetics, Incorporated\">CYTK</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a> <font color=\"green\">+7%</font>.<br><b>Losers:</b> OSH <font color=\"red\">-46%</font>. <a href=\"https://seekingalpha.com/symbol/VNDA\" title=\"Vanda Pharmaceuticals Inc.\">VNDA</a> <font color=\"red\">-16%</font>.<div class=\"tiny-share-widget\" data-id=\"1093312\" data-linked=\"Premarket gainers: ADBE +7%. UNXL +7%. CYTK +7%. SRPT +7%.Losers: OSH -46%. VNDA -16%.\" data-tweet=\"$ADBE $ADBE $UNXL - Premarket gainers: ADBE +7%. UNXL +7%. CYTK +7%. SRPT +7%.Losers: OSH -46%. VNDA -16%. https://seekingalpha.com/news/1093312?source=tweet\" data-url=\"https://seekingalpha.com/news/1093312\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093282\" data-ts=\"1371646758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGNC\" target=\"_blank\">AGNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093282\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Capital Agency (NASDAQ:AGNC) declares $1.05/share quarterly dividend. Forward yield...</a></h4><b>American Capital Agency (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AGNC\" title=\"AGNC Investment Corp.\">AGNC</a>)</b> declares $1.05/share quarterly dividend. Forward yield 16.57%. For shareholders of record June 28. Payable July 26. Ex-div date June 26. Shares <font color=\"green\">+2.5%</font> premarket. (PR)<div class=\"tiny-share-widget\" data-id=\"1093282\" data-linked=\"American Capital Agency (NASDAQ:AGNC) declares $1.05/share quarterly dividend. Forward yield...\" data-tweet=\"$AGNC - American Capital Agency (NASDAQ:AGNC) declares $1.05/share quarterly dividend. Forward yield 16.57%. For shareholders of record June 28. Payable July 26. Ex-div date June 26. Shares +2.5% premarket. (PR) https://seekingalpha.com/news/1093282?source=tweet\" data-url=\"https://seekingalpha.com/news/1093282\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093262\" data-ts=\"1371646521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093262\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Linn Energy (LINE) and LinnCo (LNCO) are upgraded to Outperform at Howard Weil, which believes...</a></h4><p>Linn Energy (LINE) and LinnCo (LNCO) are <a href=\"http://www.streetinsider.com/Upgrades/Howard+Weil+Upgrades+LINN+Energy+%28LINE%29+to+Outperform/8430035.html\" target=\"_blank\">upgraded</a> to Outperform at Howard Weil, which believes the Berry Petroleum (NASDAQ:<a href=\"https://seekingalpha.com/symbol/BRY\" title=\"Berry Petroleum Corp.\">BRY</a>) merger could be a great catalyst, providing improved organic targets and an oilier profile. While LINN's primary focus is closing the BRY deal, H2 could prove exciting with an improved organic growth program and the potential for additional large acquisitions. LINE <font color=\"green\">+1.6%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1093262\" data-linked=\"Linn Energy (LINE) and LinnCo (LNCO) are upgraded to Outperform at Howard Weil, which believes...\" data-tweet=\"$ROAN $ROAN $LNCOQ - Linn Energy (LINE) and LinnCo (LNCO) are upgraded to Outperform at Howard Weil, which believes the Berry Petroleum (NASDAQ:BRY) merger could be a great catalyst, providing improved organic targets and an oilier profile. While LINN&#39;s... https://seekingalpha.com/news/1093262?source=tweet\" data-url=\"https://seekingalpha.com/news/1093262\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093252\" data-ts=\"1371646520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSHWQ\" target=\"_blank\">OSHWQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093252\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orchard Supply (OSH) tells investors rather bluntly that it expects equity holders will...</a></h4><p>Orchard Supply (OSH) tells investors rather bluntly that it expects equity holders will experience a \"complete loss\" of their investment as a result of the pending bankruptcy. Shares were bid up early this week on speculation that the sale of assets to Lowe's would leave some value in the company. OSH <font color=\"green\">-51.5%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1093252\" data-linked=\"Orchard Supply (OSH) tells investors rather bluntly that it expects equity holders will...\" data-tweet=\"$OSHWQ - Orchard Supply (OSH) tells investors rather bluntly that it expects equity holders will experience a &quot;complete loss&quot; of their investment as a result of the pending bankruptcy. Shares were bid up early this week on speculation that the sale of a... https://seekingalpha.com/news/1093252?source=tweet\" data-url=\"https://seekingalpha.com/news/1093252\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093232\" data-ts=\"1371646180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093232\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta Therapeutics (NASDAQ:SRPT) says eteplirsen (I, II) continues to show promise in...</a></h4><p>Sarepta Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SRPT\" title=\"Sarepta Therapeutics, Inc.\">SRPT</a>) says eteplirsen (<a href=\"https://seekingalpha.com/currents/post/1057401\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/964421\" target=\"_blank\">II</a>) continues to show promise in improving the walking ability of Duchenne muscular dystrophy patients after 84 weeks. Shares <font color=\"green\">+4%</font> premarket. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1093232\" data-linked=\"Sarepta Therapeutics (NASDAQ:SRPT) says eteplirsen (I, II) continues to show promise in...\" data-tweet=\"$SRPT - Sarepta Therapeutics (NASDAQ:SRPT) says eteplirsen (I, II) continues to show promise in improving the walking ability of Duchenne muscular dystrophy patients after 84 weeks. Shares +4% premarket. (PR) https://seekingalpha.com/news/1093232?source=tweet\" data-url=\"https://seekingalpha.com/news/1093232\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093192\" data-ts=\"1371645526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNDA\" target=\"_blank\">VNDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093192\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vanda Pharmaceuticals (NASDAQ:VNDA) sinks 14% premarket after Adam Feuerstein raises questions...</a></h4><p>Vanda Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VNDA\" title=\"Vanda Pharmaceuticals Inc.\">VNDA</a>) sinks <font color=\"red\">14%</font> premarket after Adam Feuerstein <a href=\"http://www.thestreet.com/story/11954365/1/vandas-sleep-disorder-drug-is-a-nightmare.html\" target=\"_blank\">raises questions</a> about the design of the company's Phase 3 trial for Tasimelteon (<a href=\"https://seekingalpha.com/currents/post/1068231\" target=\"_blank\">previous</a>) which he says has \"changed numerous times.\" Specifically, Feuerstein notes that the company changed the primary endpoint to a measure it created which \"has never been used before in sleep-drug clinical trials [and is not ] endorsed by the FDA.\"</p><div class=\"tiny-share-widget\" data-id=\"1093192\" data-linked=\"Vanda Pharmaceuticals (NASDAQ:VNDA) sinks 14% premarket after Adam Feuerstein raises questions...\" data-tweet=\"$VNDA - Vanda Pharmaceuticals (NASDAQ:VNDA) sinks 14% premarket after Adam Feuerstein raises questions about the design of the company&#39;s Phase 3 trial for Tasimelteon (previous) which he says has &quot;changed numerous times.&quot; Specifically, Feuerstein notes ... https://seekingalpha.com/news/1093192?source=tweet\" data-url=\"https://seekingalpha.com/news/1093192\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093162\" data-ts=\"1371644988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093162\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus&#39; (VVUS +4.3%) Stendra drug for erectile dysfunction demonstrated a statistically...</a></h4><p>Vivus' (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+4.3%</font>) Stendra drug for erectile dysfunction demonstrated a statistically significant improvement vs a placebo a trial of 440 patients between the ages of 40 and 70, with the aim being for the medication to take effect within 15 minutes of being consumed. A major problem with other treatments is that patients are advised to wait 1-2 hours for the drugs take effect, or they have to be consumed daily. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1093162\" data-linked=\"Vivus&#39; (VVUS +4.3%) Stendra drug for erectile dysfunction demonstrated a statistically...\" data-tweet=\"$VVUS - Vivus&#39; (VVUS +4.3%) Stendra drug for erectile dysfunction demonstrated a statistically significant improvement vs a placebo a trial of 440 patients between the ages of 40 and 70, with the aim being for the medication to take effect within 15 min... https://seekingalpha.com/news/1093162?source=tweet\" data-url=\"https://seekingalpha.com/news/1093162\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093142\" data-ts=\"1371644544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLX\" target=\"_blank\">PLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093142\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Protalix BioTherapeutics (NYSEMKT:PLX) says the Brazilian Ministry of Health commits to purchase...</a></h4><p>Protalix BioTherapeutics (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/PLX\" title=\"Protalix BioTherapeutics, Inc\">PLX</a>) says the Brazilian Ministry of Health commits to purchase ~$40M worth of the Gaucher disease treatment alfataliglicerase per year for two years and at least that much there after as part of a \"technology transfer\" agreement. PLX <font color=\"green\">+8.3%</font> premarket. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1093142\" data-linked=\"Protalix BioTherapeutics (NYSEMKT:PLX) says the Brazilian Ministry of Health commits to purchase...\" data-tweet=\"$PLX - Protalix BioTherapeutics (NYSEMKT:PLX) says the Brazilian Ministry of Health commits to purchase ~$40M worth of the Gaucher disease treatment alfataliglicerase per year for two years and at least that much there after as part of a &quot;technology tra... https://seekingalpha.com/news/1093142?source=tweet\" data-url=\"https://seekingalpha.com/news/1093142\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093112\" data-ts=\"1371643985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093112\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cliffs Natural Resources (NYSE:CLF) -1.8% premarket after shares are downgraded to Underperform...</a></h4><p>Cliffs Natural Resources (NYSE:<a href=\"https://seekingalpha.com/symbol/CLF\" title=\"Cleveland-Cliffs, Inc.\">CLF</a>) <font color=\"red\">-1.8%</font> premarket after shares are <a href=\"http://www.streetinsider.com/Analyst+Comments/UPDATE%3A+BofAMerrill+Lynch+Downgrades+Cliffs+Natural+Resources+%28CLF%29+to+Underperform/8429794.html\" target=\"_blank\">downgraded</a> to Underperform from Neutral with a $16 price target (from $24) at BAML, which notes CLF's high cost of iron ore and met coal production. The firm thinks CLF will struggle to compete with new Australia capacity but sees no reason for a liquidity panic.</p><div class=\"tiny-share-widget\" data-id=\"1093112\" data-linked=\"Cliffs Natural Resources (NYSE:CLF) -1.8% premarket after shares are downgraded to Underperform...\" data-tweet=\"$CLF - Cliffs Natural Resources (NYSE:CLF) -1.8% premarket after shares are downgraded to Underperform from Neutral with a $16 price target (from $24) at BAML, which notes CLF&#39;s high cost of iron ore and met coal production. The firm thinks CLF will str... https://seekingalpha.com/news/1093112?source=tweet\" data-url=\"https://seekingalpha.com/news/1093112\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093102\" data-ts=\"1371643919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093102\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry (BBRY) slips 3% premarket after a downgrade to Sell at Bernstein, which sees earnings...</a></h4><p>BlackBerry (BBRY) <font color=\"red\">slips 3%</font> premarket after a <a href=\"https://twitter.com/thenotablecalls/status/347322077512097792\" target=\"_blank\">downgrade to Sell </a>at Bernstein, which sees earnings peaking in FQ1 and \"significant risk\" of a miss in H2. OTR Global says U.K. Q10 sales fell off a cliff and <a href=\"https://twitter.com/thenotablecalls/status/347323264227504130\" target=\"_blank\">have been</a>-\"not a typo\" - just 30K-50K units since launch, reports Notable Calls.</p><div class=\"tiny-share-widget\" data-id=\"1093102\" data-linked=\"BlackBerry (BBRY) slips 3% premarket after a downgrade to Sell at Bernstein, which sees earnings...\" data-tweet=\"$BB - BlackBerry (BBRY) slips 3% premarket after a downgrade to Sell at Bernstein, which sees earnings peaking in FQ1 and &quot;significant risk&quot; of a miss in H2. OTR Global says U.K. Q10 sales fell off a cliff and have been-&quot;not a typo&quot; - just 30K-50K uni... https://seekingalpha.com/news/1093102?source=tweet\" data-url=\"https://seekingalpha.com/news/1093102\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>91&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093092\" data-ts=\"1371643846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BT\" target=\"_blank\">BT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093092\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BT Group (BT -3.1%) CEO Ian Livingston will leave the company in September to become the...</a></h4><p>BT Group (<a href=\"https://seekingalpha.com/symbol/BT\" title=\"BT Group plc\">BT</a> <font color=\"red\">-3.1%</font>) CEO Ian Livingston will <a href=\"http://www.marketwatch.com/story/bt-chief-livingston-quits-to-take-government-role-2013-06-19\" target=\"_blank\">leave the company</a> in September to become the Minister of State for Trade &amp; Investment in the U.K. government. Livingston will be replaced by Gavin Patterson, who has led BT Retail and served as a BT Board member since 2008. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1093092\" data-linked=\"BT Group (BT -3.1%) CEO Ian Livingston will leave the company in September to become the...\" data-tweet=\"$BT - BT Group (BT -3.1%) CEO Ian Livingston will leave the company in September to become the Minister of State for Trade &amp; Investment in the U.K. government. Livingston will be replaced by Gavin Patterson, who has led BT Retail and served as a BT Boar... https://seekingalpha.com/news/1093092?source=tweet\" data-url=\"https://seekingalpha.com/news/1093092\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1093082\" data-ts=\"1371643665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KERX\" target=\"_blank\">KERX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1093082\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan initiates Keryx Biopharmaceuticals (KERX +1.3%) at Overweight with a price target of...</a></h4><p>JPMorgan <a href=\"http://www.benzinga.com/analyst-ratings/initiation/13/06/3688535/benzingas-top-initiations\" target=\"_blank\">initiates</a> Keryx Biopharmaceuticals (<a href=\"https://seekingalpha.com/symbol/KERX\" title=\"Keryx Biopharmaceuticals, Inc.\">KERX</a> <font color=\"green\">+1.3%</font>) at Overweight with a price target of $13, representing a near 70% upside from Tuesday's close. Shares <font color=\"green\">+4.3%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1093082\" data-linked=\"JPMorgan initiates Keryx Biopharmaceuticals (KERX +1.3%) at Overweight with a price target of...\" data-tweet=\"$KERX - JPMorgan initiates Keryx Biopharmaceuticals (KERX +1.3%) at Overweight with a price target of $13, representing a near 70% upside from Tuesday&#39;s close. Shares +4.3% premarket. https://seekingalpha.com/news/1093082?source=tweet\" data-url=\"https://seekingalpha.com/news/1093082\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1092992\" data-ts=\"1371642962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1092992\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">In a blog post announcing a partial recall of Model S vehicles, Tesla Motors...</a></h4><p>In a <a href=\"http://www.teslamotors.com/blog/partial-recall\" target=\"_blank\">blog post</a> announcing a partial recall of Model S vehicles, Tesla Motors (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a>)CEO Elon Musk notes the automaker hasn't received a single customer complaint on the issue of a potentially-weak mounting bracket. Maintaining its sense of style, the company will arrange to have recalled vehicles picked up from its owners to be fixed. TSLA <font color=\"red\">-2.0%</font> premarket to $101.30.</p><div class=\"tiny-share-widget\" data-id=\"1092992\" data-linked=\"In a blog post announcing a partial recall of Model S vehicles, Tesla Motors (NASDAQ:TSLA)CEO...\" data-tweet=\"$TSLA - In a blog post announcing a partial recall of Model S vehicles, Tesla Motors (NASDAQ:TSLA)CEO Elon Musk notes the automaker hasn&#39;t received a single customer complaint on the issue of a potentially-weak mounting bracket. Maintaining its sense o... https://seekingalpha.com/news/1092992?source=tweet\" data-url=\"https://seekingalpha.com/news/1092992\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1092972\" data-ts=\"1371642858\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTEK\" target=\"_blank\">TTEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1092972\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tetra Tech (NASDAQ:TTEK) -10.2% premarket after saying yesterday it expects to post an FQ3 loss...</a></h4><p>Tetra Tech (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TTEK\" title=\"Tetra Tech, Inc.\">TTEK</a>) <font color=\"red\">-10.2%</font> premarket after saying yesterday it <a href=\"https://seekingalpha.com/currents/post/1092232\" target=\"_blank\">expects to post an FQ3 loss</a> due to higher than expected restructuring costs related to its eastern Canada and mining operations. Brean Capital <a href=\"http://www.streetinsider.com/Downgrades/Brean+Capital+Downgrades+Tetra+Tech+%28TTEK%29+to+Hold/8429895.html\" target=\"_blank\">downgrades</a> TTEK to Hold from Buy, noting the pre-announcement implies that it will be several quarters before the company regains its footing in terms of overall profitability.</p><div class=\"tiny-share-widget\" data-id=\"1092972\" data-linked=\"Tetra Tech (NASDAQ:TTEK) -10.2% premarket after saying yesterday it expects to post an FQ3 loss...\" data-tweet=\"$TTEK - Tetra Tech (NASDAQ:TTEK) -10.2% premarket after saying yesterday it expects to post an FQ3 loss due to higher than expected restructuring costs related to its eastern Canada and mining operations. Brean Capital downgrades TTEK to Hold from Buy, ... https://seekingalpha.com/news/1092972?source=tweet\" data-url=\"https://seekingalpha.com/news/1092972\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1092812\" data-ts=\"1371639678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTGE\" target=\"_blank\">MTGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1092812\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Capital Mortgage (NASDAQ:MTGE) gained 2.4% AH following an 11% cut in its quarterly...</a></h4><p>American Capital Mortgage (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MTGE\" title=\"MTGE Investment Corp.\">MTGE</a>) <font color=\"green\">gained 2.4%</font> AH following an 11% cut in its quarterly dividend to $0.80/share, an annualized yield of 15.8% based on yesterday's close. <a href=\"https://seekingalpha.com/currents/post/1092782\" target=\"_blank\">Previous</a>: SIster company American Capital Agency cuts dividend 16%. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1092812\" data-linked=\"American Capital Mortgage (NASDAQ:MTGE) gained 2.4% AH following an 11% cut in its quarterly...\" data-tweet=\"$MTGE - American Capital Mortgage (NASDAQ:MTGE) gained 2.4% AH following an 11% cut in its quarterly dividend to $0.80/share, an annualized yield of 15.8% based on yesterday&#39;s close. Previous: SIster company American Capital Agency cuts dividend 16%. (PR) https://seekingalpha.com/news/1092812?source=tweet\" data-url=\"https://seekingalpha.com/news/1092812\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1092782\" data-ts=\"1371639399\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGNC\" target=\"_blank\">AGNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1092782\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Capital Agency (NASDAQ:AGNC) gains 2.5% premarket after cutting its quarterly dividend...</a></h4><p>American Capital Agency (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AGNC\" title=\"AGNC Investment Corp.\">AGNC</a>) <font color=\"green\">gains 2.5%</font> premarket after cutting its quarterly dividend 16% to $1.05/share, a 16.6% annualized yield based on last night's close, suggesting the cuts aren't over with. SA Pro's Dane Bowler <a href=\"https://seekingalpha.com/currents/post/999141\" target=\"_blank\">a month ago suggested</a> an annual payout of about $3.50 as a \"sustainable\" level for the dividend.(PR)</p><div class=\"tiny-share-widget\" data-id=\"1092782\" data-linked=\"American Capital Agency (NASDAQ:AGNC) gains 2.5% premarket after cutting its quarterly dividend...\" data-tweet=\"$AGNC - American Capital Agency (NASDAQ:AGNC) gains 2.5% premarket after cutting its quarterly dividend 16% to $1.05/share, a 16.6% annualized yield based on last night&#39;s close, suggesting the cuts aren&#39;t over with. SA Pro&#39;s Dane Bowler a month ago sugg... https://seekingalpha.com/news/1092782?source=tweet\" data-url=\"https://seekingalpha.com/news/1092782\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1092692\" data-ts=\"1371632751\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NWS\" target=\"_blank\">NWS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1092692\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares in new News Corp. (NASDAQ:NWS), which will hold the company&#39;s publishing assets when it...</a></h4><p>Shares in new News Corp. (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NWS\" title=\"News Corporation\">NWS</a>), which will hold the company's publishing assets when it splits on June 28, <font color=\"red\">fell 3%</font> to $14.55 <a href=\"http://news.theage.com.au/breaking-news-business/new-news-corp-fails-to-impress-on-debut-20130619-2oibn.html\" target=\"_blank\">on their trading debut in Sydney</a> after opening at a lower-than-expected $15. The non-voting stock slumped over 8% to $14.30. Due to the split, shares in 21st Century Fox, the entertainment business that comprises the other half of News Corp and is still trading under the parent company's name for now, <font color=\"red\">dropped 6.9%</font> to $30.53.</p><div class=\"tiny-share-widget\" data-id=\"1092692\" data-linked=\"Shares in new News Corp. (NASDAQ:NWS), which will hold the company&#39;s publishing assets when it...\" data-tweet=\"$NWS - Shares in new News Corp. (NASDAQ:NWS), which will hold the company&#39;s publishing assets when it splits on June 28, fell 3% to $14.55 on their trading debut in Sydney after opening at a lower-than-expected $15. The non-voting stock slumped over 8% ... https://seekingalpha.com/news/1092692?source=tweet\" data-url=\"https://seekingalpha.com/news/1092692\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1092652\" data-ts=\"1371630123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEZ\" target=\"_blank\">FEZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1092652\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European shares (NYSEARCA:FEZ) mostly fall as investors adjust their positions ahead of the Fed,...</a></h4><p>European shares (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/FEZ\" title=\"SPDR EURO STOXX 50 ETF\">FEZ</a>) mostly fall as investors adjust their positions ahead of the Fed, although there does seem to be increasing confidence that the FOMC won't signal the end of its QE program today. \"There is <a href=\"http://www.reuters.com/article/2013/06/19/markets-global-idUSL5N0EU3J120130619\" target=\"_blank\">a lot of slack</a> in the economy and there is no inflation pressure,\" says Standard Chartered's Ned Rumpeltin. EU Stoxx 50 <font color=\"red\">-0.1%</font>, London <font color=\"red\">-0.7%</font>, Paris <font color=\"red\">-0.6%</font>, Frankfurt <font color=\"red\">-0.7%</font>, Madrid <font color=\"green\">+0.5%</font>, Milan flat.</p><div class=\"tiny-share-widget\" data-id=\"1092652\" data-linked=\"European shares (NYSEARCA:FEZ) mostly fall as investors adjust their positions ahead of the Fed,...\" data-tweet=\"$FEZ - European shares (NYSEARCA:FEZ) mostly fall as investors adjust their positions ahead of the Fed, although there does seem to be increasing confidence that the FOMC won&#39;t signal the end of its QE program today. &quot;There is a lot of slack in the econ... https://seekingalpha.com/news/1092652?source=tweet\" data-url=\"https://seekingalpha.com/news/1092652\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1092642\" data-ts=\"1371629499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXJ\" target=\"_blank\">DXJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1092642\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Japanese shares (NYSEARCA:DXJ) buck the trend in Asia and rise 1.8% after exports jump a...</a></h4><a target=\"_blank\" href=\"http://www.bloomberg.com/news/2013-06-19/japan-shares-rise-fourth-day-on-weak-yen-rising-exports.html\">Japanese shares</a> (NYSEARCA:<a href='https://seekingalpha.com/symbol/DXJ' title='WisdomTree Japan Hedged Equity ETF'>DXJ</a>) buck the trend in Asia and <font color=\"green\">rise 1.8%</font> after exports jump a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1092562\">better-than-expected</a> 10.1%, with Sony and SoftBank rising on corporate news (<a target=\"_blank\" href=\"https://seekingalpha.com/currents/search?query=sony%20loeb\">I</a>, <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1092542\">II</a>). Stocks elsewhere in the region fall as investors stay cautious ahead of the FOMC monetary policy announcement later. Hong Kong <font color=\"red\">-1.1%</font>, China <font color=\"red\">-0.7%</font>, India <font color=\"red\">-0.3%</font>.<div class=\"tiny-share-widget\" data-id=\"1092642\" data-linked=\"Japanese shares (NYSEARCA:DXJ) buck the trend in Asia and rise 1.8% after exports jump a...\" data-tweet=\"$DXJ $EWJ $NKY - Japanese shares (NYSEARCA:DXJ) buck the trend in Asia and rise 1.8% after exports jump a better-than-expected 10.1%, with Sony and SoftBank rising on corporate news (I, II). Stocks elsewhere in the region fall as investors stay cautious... https://seekingalpha.com/news/1092642?source=tweet\" data-url=\"https://seekingalpha.com/news/1092642\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}